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Abstract
Objectives: A multifactorial approach is recommended for the identification/diagnosis,
prognosis, and treatment of pain in knee osteoarthritis (OA). One aspect of this approach
includes illness perception and behaviour. The purpose of this thesis was to investigate the
measurement of illness perception and behaviour along a continuum of symptomatic knee
OA, starting from the early symptoms of knee OA.
Methods: Three studies were conducted to fulfill this purpose. The first study was a scoping
review that applied an interpretative analysis to validated measures that had been used to
assess people with knee pain and/or knee OA. Second was the construct validation of a
measure of illness perception and behaviour in people with early symptoms of knee OA and
confirmed knee OA. Third was a study of a rat model of post-traumatic knee OA that was
undertaken to identify behavioural measures that were significantly different between rats
with and without knee OA.
Results: The scoping review identified 16 validated measures that capture components of
illness perception and behaviour. Only one measure, the Questionnaire to Identify Knee
Symptoms (QuIKS), capture all four components of illness perception and behaviour. In the
second study, a version of the QuIKS called the QuIKS-R was found to be unidimensional
and to provide interval-level scaling of illness perception and behaviour. In the third study,
ipsilateral weight-bearing deficit and vertical activity limitations were identified as two
behavioural measures that differed between the rat model of post-traumatic knee OA and
control groups.
Conclusions: The three studies in this thesis identified measures that could be important in
advancing the identification and care of people with symptoms of knee OA, in terms of
clinical care, clinical research with humans and preclinical research with the rat model of
post-traumatic knee OA.
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Chapter 1
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General Introduction

At the foundation of this thesis is the quest for a deeper understanding of the measurement
of ‘illness perception and behaviour’ in the experience of symptomatic knee osteoarthritis
(OA). According to Petri et al. (2007; p. 163), illness perception as a unique concept can be
defined as “the organized cognitive representations or beliefs that patients [or people] have
about their illness”.1 In general, behaviours are the internally coordinated responses (action
or inaction) to internal or external stimuli, with the exclusion of developmental changes.2 In
contrast, ‘illness perception and behaviour’ is used as a unified concept in this thesis by
applying Mechanic’s (1986; p. 1) definition of illness behaviour, which states that “it
[illness behaviour] refers to the manner in which individuals monitor their bodies, define
and interpret their symptoms, take remedial action, and utilize sources of help as well as the
more formal health care system”.3
In this thesis, a transdisciplinary approach was used to study the assessment of illness
perception and behaviour along a continuum of symptomatic knee OA. This means the
dissertation is comprised of both human and animal studies.

1.1

Knee OA

The knees are among the most common sites of OA. Knee OA is usually debilitating, is
characterized by joint deterioration at the level of the articular cartilage as part of the wider
disruption of the biology of the whole joint, and can result in varied levels of pain in and/or
around the knee, loss of physical functioning, activity limitations, participation restrictions,
psychological distress, and reduced quality of life.4-6 Recently, the Osteoarthritis Research
Society International (OARSI) proposed a standardized definition of OA that reads,
“Osteoarthritis is a disorder involving movable joints characterized by cell stress and
extracellular matrix degradation initiated by micro- and macro-injury that activates
maladaptive repair responses including pro-inflammatory pathways of innate immunity.
1

The disease manifests first as a molecular derangement (abnormal joint tissue metabolism)
followed by anatomic, and/or physiologic derangements (characterized by cartilage
degradation, bone remodeling, osteophyte formation, joint inflammation and loss of normal
joint function), that can culminate in illness”.7, 8
Knee pain is a reliable indicator of symptomatic knee OA, even when OA-related structural
changes of the joint are not present on plain radiographs.5, 6, 9, 10 While knee pain is an
integral part of the clinical diagnosis of symptomatic knee OA in people aged 40 years and
over,9, 11 it should be recognized that there is a discordance between the presence of knee
pain and radiographic knee OA.12, 13 One review found that 15% to 76% of people with
knee pain had radiographic knee OA, whereas 15% to 81% of people with radiographic
knee OA had knee pain.12 Also, the prevalence of symptomatic knee OA is generally lower
than its radiographic counterpart, and the definition of symptomatic knee OA affects
estimates of its prevalence.9, 14
The prevalence of symptomatic knee OA varies around the world. The crude prevalence
estimates fall between 5.4% and 24.2% in adult populations, and prevalence rates are
highest in older age groups.14 In general, over 10% but fewer than 25% of people aged 50
years or more have been reported to have symptomatic knee OA.14 For example, in the
United States of America (US), symptomatic knee OA is reported to affect about 10% of
men and 13% of women aged 60 years or more.5 Another US study showed that the
prevalence of both knee pain and symptomatic knee OA has been on the rise, increasing
twofold or more from 1983 through 2005 in a community cohort of people aged over 70
years.15 Subsequently, data from a 2007 to 2008 nationwide survey in the US estimated a
13.8% lifetime risk for symptomatic knee OA in people aged 25 years or more.16
Furthermore, the estimated lifetime risk was as low as 0.7% for non-obese men aged 25
years to 34 years and rose to 32.4% for obese women aged 85 years or more.

2

1.2

Impact and management of knee OA in Canada

In Canada, 13% (4.4 million) of the population aged 15 years or more had OA in 2010 with
a forecasted increase to 22.9% by 2032.17 It has been estimated that $488 billion dollars
could potentially be saved in the direct and indirect costs of OA between 2010 and 2040 if
adequate pain management strategies for OA are implemented.17 Knee OA has had a
substantial financial burden on individuals and society. For example, $398 million dollars
were spent on acute care during hospitalization for unilateral knee replacements in 20122013, making it by far the most costly intervention in Canada for that year.18 Accordingly,
in the year 2013 to 2014, knee OA was the fifth highest reason for hospitalization, in terms
of volume and average length of stay, in Canada.19
No cure currently exists for knee OA.20 However, important strategies for combatting
symptomatic knee OA include early recognition and application of self-management
techniques, and clinical intervention strategies such as exercise, patient education and
weight-loss.21-29 In line with established clinical guidelines, knee OA is typically treated
with various types of conservative treatments, pharmacotherapies, and surgical modalities
that are focused on relieving knee pain and discomfort, augmenting functional capacity,
maintaining and improving physical activity levels, and thus on improving quality of life.2129

When less invasive and aggressive therapies fail to resolve the ill-effects of knee OA, total
knee replacement (TKR) has become the standard approach for treating end-stage knee
OA.21-30 Between 2013 and 2014, a total of 59,388 knee replacement surgeries were
performed in Canada, which constituted the second most frequently performed surgical
intervention in the country, second only to caesarean section.19 In that same year, 97.1% of
all TKRs were for treating knee OA.31 Additionally, compared to five years earlier, 8.5%
more total joint replacements were performed, which constituted a 14.8% to 16.0% increase
in TKRs among people aged 45 to 64 years, whilst TKR remained most prevalent among
those between 65 and 84 years of age.31 Yet one Canadian study found that 14% to 28% of
people who received primary TKR in Ontario were not satisfied with pain relief and 16% to
30% were not satisfied with their level of function.32 Also, one study found a little over 1%
to about 7% of artificial knee joints did not survive beyond 10 years.33 This raises concerns,
3

especially given the increase in younger people having the procedure, and the current trend
in greater life expectancy and population age in Canada.31, 34 The preceding facts reflect the
need to implement strategies to detect and manage symptomatic knee OA earlier in primary
care practice and in community settings in order to delay or prevent the need for knee
replacement surgeries.

1.3

Assessment of symptomatic knee OA

It is imperative that symptomatic knee OA is recognized during its early stages, if
appropriate primary care interventions are to be effectively utilized. Kittelson et al. (2014)
shared their perspective that the future of diagnosis, prognosis and treatment of
symptomatic knee OA rests on leveraging the equitable contribution of knee joint
pathology, pain neurophysiology, and psychological distress to the phenotypes of pain in
knee OA.35 Imaging technologies are the standard measures for diagnosing knee OA.6, 36
While imaging technologies focus on structural changes at the joint, pain and disability are
among the main reasons people with knee OA seek care.37 The measurement of knee pain
and physical, psychological, and social functioning factors related to knee OA are usually
subjective and require self-reporting by the affected individual.38-40 Psychological distress
(cognitive, psychosocial, and behavioural factors) plays an integral role in the
recognition/diagnosis and treatment of symptomatic knee OA, and is consistent with what
individuals report about their lived experiences with knee pain/OA.41-44

1.4

Lived experience with symptomatic knee OA

During the last decade, several qualitative studies have made important contributions to our
understanding of the lived experiences of people with knee pain/OA.41-44 A systematic
review of qualitative studies on people with OA, with a majority having knee OA, showed
that people’s attitudes were influenced by how severe their OA symptoms were, whether
their level of function was affected, how much they knew about the disease, and how they
perceived others viewed their condition.42 Among these people, an overarching theme was
4

that their decision to seek professional diagnosis was delayed while they self-managed their
condition and gathered information through informal rather than formal sources.42
Diagnosis was not sought until people reached a critical point. Even then, self-management
continued until there was an ‘inevitable’ need for knee joint replacement.43 A qualitative
meta-synthesis found that the decision to undergo TKR was shaped by one’s experience
with pain, the perceived role of health professionals, thoughts on the treatment options and
outcomes, the perceived cause of the condition, and social context.41 Subsequently, postsurgery recovery outcomes, both short and long term, were thought to be determined by
one’s life context and coping strategies.41
In the context of people living in Canada with mild-to-moderate symptomatic knee OA or
knee OA-like pain, their attitudes, behaviours, beliefs, intentions, and perceptions are
related to how their knee symptoms shape their lived experience.45-49 These contextual
factors have been implicated in the negative effects of the early symptoms of knee OA,
effect such as decreased engagement in meaningful physical activity and social roles, and
deteriorated emotional wellbeing.45-49 Furthermore, contextual factors were implicated in
the evaluation of one’s own health, the search for information, the implementation of selfmanagement strategies, the seeking of lay-person and professional care provider support
through interpersonal interactions and for conservative treatment, and finally the seemingly
inevitable decision for surgery.45-49

1.5

Measures of illness perception and behaviour

Illness perception and behaviour has been operationalized in many measures that have been
used to assess attitudes, behaviours, beliefs, coping strategies, and perceptions related to
illness in people with various medical conditions.1, 50, 51 Consistent across the studies of its
conceptualization and operationalization, is the message of the importance of illness
perception and behaviour in the recognition and management of medical conditions, and
the demonstration of it having significant associations with physical and psychological
adjustments to medical conditions.3, 50-52 The measurement of illness perception and
behaviour as it relates to knee symptoms could be critical for the implementation of
5

professional-guided conservative management strategies in early symptomatic knee OA.49,
53

For example, one study successfully used ‘illness behaviour’ as the first filter in a model

that identified people with hip or knee pain problems within the community who have OA
and utilized health care.54, 55 Self-report questionnaires such as the Arthritis Self-Efficacy
Scale (ASES) have measured the beliefs of people with symptomatic knee OA regarding
their ability to manage their pain, the presence of other symptoms, and the performance of
certain physical functions.56, 57 These beliefs have been important outcomes associated with
pain and the level of physical function of people with symptomatic knee OA who
participated in various arthritis self-management programs.56, 57
Some questions about the development, progression and treatment of knee OA are too
challenging to be conducted using humans due to the cost and time required to monitor
people over many years. Using an animal model provides experimental control over the
induction of OA with varying degrees of severity and also provides more certainty around
the establishment of mild-to-moderate OA structural changes in relatively short timelines.
Furthermore, animal samples can be controlled to have high levels of biological
homogeneity. These characteristics make animal models attractive for studying the
measurement of the joint pathological and the pain neurophysiological aspects of OA, as
well as the measurement of the psychological-related components of OA such as changes in
behaviour.

1.6

Rodent models in knee OA research

Rodent models are commonly used as surrogates for the study of knee OA in humans.58
They allow for the experimental study of knee OA in ways that would normally be
considered unethical, even impossible in human beings, such as the induction of disease and
sacrifice after a therapeutic intervention.59 There are several rodent models of knee OA that
are based mostly on methods of chemical induction (e.g. mono-sodium iodoacetate) or
surgical induction (e.g. anterior cruciate ligament transection).58 The surgically-induced
rodent models are particularly relevant to the study of post-traumatic knee OA.58

6

In humans, an anterior cruciate ligament (ACL) tear increases the risk of symptomatic knee
OA, with up to 80% of people developing radiographic knee OA and up to 46% developing
symptomatic knee OA within 10 to 15 years.60-62 People with ACL reconstruction and
meniscectomy are more likely to have knee OA than people with ACL reconstruction and a
normal meniscus.60, 63 Furthermore, there is no convincing evidence that surgical
interventions for knee joint injury protect against future knee OA.64 Rat models of knee OA
that were created through destabilizing the knee joint using ACL transection and
meniscectomy have been reported to demonstrate structural joint changes characteristic of
knee OA within as little as two weeks after the operation.65 Thus, the knee OA pathology
and its response to therapy can be studied in a relatively short period of time and without
injury to humans.
While pain and disability in humans with knee OA are typically assessed using self-reports
and performance-based measures, the histology of joint changes and reflexes evoked by
sensory stimuli are usually the primary outcome measures in preclinical rodent models of
knee OA.39, 66-68 This difference in measuring the effectiveness of therapies challenges the
translation of preclinical research to clinical settings, because important components of the
phenotype of the condition are not accounted for when evaluating the outcomes of
preclinical rodent research.67, 69 Behavioural measures of pain in rodent models of knee OA
provide a closer and more realistic measure of clinical pain.58, 69-72 Therefore, including
assessments of behavioural changes, such as changes in physical activity, in preclinical
rodent models of knee OA could provide information comparable to self-report or
observational methods of illness response in humans.67, 69 To fill this gap, the assessment of
behavioural alterations such as changes in physical activities, possibly brought on by
movement-induced pain, are becoming more of an integral part of assessing the outcomes
of experiments using rodent models of knee OA.58, 69-73 These behavioural outcomes include
measures such as changes in gait, weight-bearing symmetry, and locomotor activity.58, 69-73
The inclusion of these measures better account for the complexity that forms the experience
of having knee OA. Furthermore, the inclusion of behavioural measures as outcomes in
research using rodent models of knee OA is thought to increase the validity of the models.69

7

1.7

Overarching Objective

Illness perception and behaviour is an important aspect of the lived experience of people
with symptomatic knee OA. If properly measured, illness perception and behaviour could
help in providing more well-rounded descriptions of an individual with knee pain/OA
condition for informing the individual’s therapy. Therefore, the overarching objective of
this thesis was to identify measures of illness perception and behaviour used with people
that are on a continuum of symptomatic knee OA with a greater emphasis on emergent and
early stages of symptomatic knee OA. Also, my transdisciplinary approach sought to
identify measures of behaviour in a preclinical rat model of knee OA with joint pathology
characteristic of mild-to-moderate knee OA.

1.8

Research plan

A systematic synthesis of the research literature that documents validated measures of
illness perception and behaviour in people with knee pain/OA does not exist. Undertaking
such a study was considered to be a valuable first step in assessing the need for a measure
that captures the illness perception and behaviour of people with emergent or early
symptomatic knee OA. It is expected that a measure of illness perception and behaviour
could be integral in the recognition of people as members of this population during primary
care consultation or in the community and later in the selection of appropriate treatment
protocols.74 Beyond synthesizing the research literature on these measures, an interpretive
approach was planned as a part of the methodology of the review. This was planned in order
to understand how comprehensively the measures assess illness perception and behaviour.
As a natural extension to the findings of the systematic synthesis, a psychometric evaluation
was planned for the Questionnaire to Identify Knee Symptoms (QuIKS) to strengthen its
value as an assessment measure of illness perception and behaviour for use to identify
people who are experiencing some symptoms consistent with knee OA. This second study
was needed to raise its scaling to an interval-level as recommended as a part of the
development and validation of measurement methods.75 In this second study, plans were
8

made to provide preliminary interpretation of the QuIKS’s interval-level scale using a
known-group analysis of people along a continuum of symptomatic knee OA.
The third and final study was planned as a contribution to the development of a more robust
rat model of knee OA that integrates behavioural alteration due to knee OA as a component
of the model. The plan was to investigate certain behaviours that are an integral part of the
human experience of knee OA for their possible use as outcome measures that could be
routinely included in studies using a preclinical rat model of post-traumatic knee OA.
The three studies are presented in the next three chapters. Chapter two is a scoping review
of validated measures that were interpreted as assessors of illness perception and behaviour
in people with knee pain/OA. Chapter three is a version of the QuIKS that provides
interval-level scaling for the measurement of illness perception and behaviour for people
along a continuum of symptomatic knee OA. Chapter four provides behavioural measures
that can form a part of routine outcome measurement in a surgically-induced rat model of
post-traumatic knee OA. The final chapter of the thesis provides a discussion of the totality
of the research conducted including implications for management for people with knee OA
and future research directions.
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Chapter 2

2

Validated measures of illness perception and behaviour

A version of this chapter is presently under review for publication in a peer-reviewed
journal.

2.1

Abstract

Objective: To identify validated measures that capture illness perception and behavior and
have been used to assess people who have knee pain/osteoarthritis (OA).
Methods: A scoping review was performed. Nine electronic databases were searched for
records from inception through April 19, 2015. Search terms included illness perception and
behavior, knee, pain, osteoarthritis, and their related terms. This review included English
language publications of primary data on people with knee pain/OA assessed with validated
measures capturing any of four components of illness perception and behavior: monitor
body, define and interpret symptoms, take remedial action, and utilize sources of help.
Initially, one reviewer screened the titles and abstracts of 11,151 publications. Then, two
reviewers independently screened the full-text of 153 publications. Subsequently, 71
publications were analyzed. Two reviewers independently charted and coded the measures
into the four components.
Results: Sixteen measures were identified that capture components of illness perception
and behavior in the target population. Coding results indicated that 31, 69, 75 and 31
percent of these measures included the monitor body, define and interpret symptoms, take
remedial action, and utilize sources of help components, respectively.
Conclusions: Several validated measures were interpreted as capturing some components,
and only one measure was interpreted as capturing all of the components of illness
perception and behavior in the target population. A measure that comprehensively captures
illness perception and behavior could be valuable for informing and evaluating therapy for
patients along a continuum of symptomatic knee OA.
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2.2

Introduction

Thirteen percent of Canadians had OA in 2010, with a projected increase to 22.9% by
2032.1 In the United States (US), the estimated lifetime risk of developing symptomatic
knee OA is 13.8% for adults aged 25 years and more.2 People with knee pain and knee OA
represent a large and growing global population of people with disability.3,4 Accordingly,
knee OA is the leading cause of chronic disability among community-dwelling older adults,
primarily due to knee pain.5, 6 Furthermore, people with symptomatic knee OA may have
substantial inter-individual variation in their illness response, such as seeking care and
taking medication.7,8
A number of theories and models from the behavioural and social sciences identify concepts
that are relevant to the ways that individuals with health conditions appraise, evaluate,
perceive and respond to illness.9-16 They include theories related broadly to stress, coping
and adaptation; theories that discuss individual differences or personality and its
relationship to illness responses, as well as biopsychosocial frameworks or theories that are
specific to managing diseases, illnesses or other health problems.9-16 For example,
Mechanic (1986: p.1) defined illness behaviour as “the manner in which persons monitor
their bodies, define and interpret their symptoms, take remedial action, and utilize various
sources of help including the formal health-care system”.17 Research on illness perception
and behaviour is scattered and segmented in the medical literature, covering concepts such
as appraisals, perceptions, coping strategies, care-seeking behaviour, sick roles, and
personal difference factors.18-20 The broad concepts surrounding illness responses fit with
the contemporary biopsychosocial framework, which views illness as a complex
relationship between biomedical and psychosocial factors.16,20,21
Three main models of illness contributed to our understanding of illness perception and
behaviour as it applies to knee pain/OA. First is the model of illness behaviour.14 This
model describes different phases in order to explain an individual’s decision-making when
seeking relief during illness. These include the recognition, appraisal and labeling of an
illness; evaluating the meaning and significance of the illness; responses to health problems
such as seeking out and assessing treatment options and weighing the benefits and costs of
treatment; and illness management responses or behaviours like selecting and adhering to a
17

treatment plan. Finally, any new information or health changes are re-evaluated, making the
model cyclical as an individual may return to some of the previous phases.14
Second is the common-sense model of illness representation (or Leventhal’s self-regulatory
model of illness behaviour).16,22 It has several parallels with the model of illness behaviour.
For example, both models describe the role of illness history and the somatic self in
determining how information about an illness is processed.14,16 The common-sense model
pays specific attention to the role that internal and external influences play in cognitive and
emotional responses to stimuli, in appraisal, and in coping, with particular focus on
personality variables or individual difference factors, as well as cultural and interpersonal
contexts.16 In the common-sense model, cognitive level processes or health threats revolve
around five attributes of illness representation: the identity of the illness, the timeline that
describes the duration and pattern of symptoms, the attributable causes that elicit
symptoms, the perceived controllability of the stimuli, and the imagined consequences of
the illness.16
Third is the model of selective optimization with compensation, which describes a general
process of adaptation that can be applied to any illness.15,23 The model has previously been
described for the adaptation of older adults with OA to disability.23 It has three components:
selection, the giving up or restriction of activities because of reduced functional capacity;
optimization, the individual’s augmentation of their capacity to engage in desired tasks; and
compensation, the changing of strategies used to continue engaging in specific tasks despite
the loss of capacity.23
Previous reviews have looked at the conceptualization and operationalization of illness
perceptions, appraisals and behaviours.18-20,24 These reviews have also highlighted their
importance in the assessment and management of health conditions by clinicians.18-20 Prior
and Bond (2013) noted that the primary purpose of the operationalization of illness
behaviour is for individual-level assessment of the illness response, and posited the idea that
illness behaviour has both covert (affective and cognitive) and overt (observable)
aspects.20,25 Consistent with this, Sirri et al (2013) argued that illness behaviour unifies
diverse concepts in the medical literature that may improve illness recognition and a
18

patient’s medical care.18 Moreover, these concepts not only may help clinicians better
understand decision making, coping, self-management, and treatment adherence; but they
may also be useful as outcome measures of change in perceptions or behaviours after
treatment.
In the present study, measures were sought that capture illness perception and behaviour
and which could be used during the rehabilitation of people with knee symptoms consistent
with symptomatic knee OA. Therefore, the aim of this study was to identify validated
measures that capture illness perception and behaviour and were used to assess people who
have knee pain/OA.

2.3
2.3.1

Methods
Study design

The published research literature was reviewed using the systematic methodological
framework for scoping studies developed by Arksey and O’Malley (2005).26 This study also
incorporated some of the recommendations for its enhancement when used in health
research.27,28 Following this framework, we: 1) identified the research question, 2)
identified relevant publications, 3) selected the qualifying publications, 4) charted the data,
5) collated, summarized, and reported the results, and 6) consulted with stakeholders, which
included two experts in psychosocial theory, chronic diseases such as OA, rehabilitation,
and measurement.

2.3.1.1

Stage 1: Identification of the research question

First we formulated the following research question: What are the available validated
measures of illness perception and behaviour used with people who have knee pain and
knee OA? Illness perception and behaviour as a unified concept followed Mechanic’s
(1986) definition of illness behaviour.17 This definition is applicable to clinical management
of pain/OA because it encompasses both covert and overt responses to illness.20
19

2.3.1.2

Stage 2: Identification of relevant publications

Search strategy. The search strategy was informed by a health sciences librarian. Search
was done of all the online records up to October 20, 2014 of nine electronic databases and
grey literature, namely: AMED, CINAHL, Cochrane Library, EMBASE, Health and
Psychosocial Instruments, Open Grey, ProQuest Research Library (all 65 databases),
PubMed, and Web of Knowledge. Using Boolean logic, the search terms included: illness
behaviour, knee, pain, and osteoarthritis, each with related terms. Box 2.1 provides a full
list of the search terms. One co-author (C.B.H. and M-K.W.) screened the reference list of
the publications included in the final selection. Also, the names of the eligible validated
measures were used to search for additional relevant publications.
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Box 2.1. Search strategy for identifying studies before consultation
•

Databases (inception to October 14, 2014)

AMED, CINAHL, Cochrane Library, EMBASE, Health and Psychosocial
Instruments, Open Grey, ProQuest Research Library (all 65 databases), PubMed,
and Web of Knowledge
•

Search terms

[Illness perception and behaviour related terms: “sick role” OR “illness
behaviour/behavior” OR “help seeking behaviour/behavior” OR “health seeking
behaviour/behavior” OR “information seeking behaviour/behavior” OR “care
seeking behaviour/behavior” OR “health care seeking behaviour/behaviour” OR
“healthcare seeking behaviour/behavior” OR “self-care” OR “pain
behaviour/behavior” OR “self-management” OR “treatment seeking
behaviour/behavior” OR “adaptive behaviour/behavior” OR “health care
utilization” OR “information seeking” OR “coping behaviour/behavior” OR
“coping behavior” OR “illness response” OR “severity of illness index” OR
“severity of illness indices” OR “illness experience” OR “treatment adherence”
OR “symptoms response” OR “pain response” OR “self-regulation” OR
“professional regulation” OR “professional care” OR “self-monitoring”] AND
[Knee related terms: “knee” OR “knee joint” OR “patellofemoral joint” OR
“tibiofemoral”] AND [The condition related terms: “pain” OR “osteoarthritis”
OR “knee osteoarthritis” OR “osteoarthritis, knee”]
•

Journals

None searched
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2.3.1.3

Stage 3: Study selection

Inclusion criteria. We defined the four components of illness perception and behaviour
identified within Mechanic’s (1986) definition,17 (see Box 2.2.): (i) Monitor body means
maintaining focus on the occurrence of symptoms and factors contributing to symptom
episodes.29 (ii) Define and interpret symptoms refers to an individual’s attempt to decipher
22

meaning and place significance on their symptoms including their perceived ability to
manage them.29 (iii) Take remedial action means applying lay- or professionally-guided
care to control one’s symptoms or progression of the disease, such as the avoidance of knee
pain triggering activities, the use of pain medication, or self-talk.30,31 (iv) Utilize sources of
help means help through interpersonal interaction with either lay or professional care
providers regarding one’s illness or symptoms.31,32 We included quantitative studies that
reported primary data from people with knee pain/OA, who were assessed with a measure
that was previously validated or validated as part of the study. Measures were considered
validated if, at the minimum, they had evidence of content validation in any population.
Also, each measure had to be available in English and provide an individual-level scoring
method. The full version of each validated measure or its validated subsections (e.g.
subscales or factors) were eligible. Furthermore, the validated measure had to be interpreted
as capturing one or more components of illness perception and behaviour.
Exclusion criteria. We excluded animal studies, qualitative studies, and publications that
were not available in English. Publications were also excluded when subjects were
diagnosed with rheumatoid arthritis, fibromyalgia, generalized pain, generalized OA, or
were post-surgical. Also, exclusion during full-text screening focused on the following four
criteria: the publication: 1) did not use a validated measure of illness perception and
behaviour; 2) did not specify a sample with knee pain and/or knee OA; 3) contained a nonEnglish measure with no evidence of cross-cultural validation with an English language
equivalent; and 4) a full-text or measure was not found.
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Box 2.2. Definition of illness perception and behaviour components
•

Monitor body means maintaining focus on the occurrence of symptoms and
factors contributing to symptom episodes.

•

Define and interpret symptoms refers to an individual’s attempt to decipher
meaning and place significance on their symptoms including their perceived
ability to manage them.

•

Take remedial action means applying lay- or professionally-guided care to
control one’s symptoms or progression of the disease, such as the avoidance of
knee pain triggering activities, the use of pain medication, or self-talk.

•

Utilize sources of help means help through interpersonal interaction with either
lay or professional care providers regarding one’s illness or symptoms.
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Screening, full-text and measure review. All of the retrieved publications were placed in a
citation management system. A sample of 300 publications was independently screened by
two reviewers (C.B.H. and M-K.W.). This was done to refine the inclusion and exclusion
criteria. In a sequential and iterative process, one reviewer (C.B.H.) screened the titles and
abstracts of all the initial set of publications retrieved by the search strategy. Some
publications were excluded at this stage. We retrieved those publications judged to be
possibly eligible. Then, full-text review of the remaining publications was independently
performed by two reviewers (C.B.H. and M-K.W.). When the reviewers disagreed on
eligibility, advice was sought from a third investigator (B.M.C.), and the decision was made
by consensus on whether to include the publication. We then retrieved the measures from
the included publications. The final decision to include a publication consisted of analysing
each item of the relevant validated measure by assessing how well it fit with the definition
of each of the four components.

2.3.1.4

Stage 4: Charting the data

A data charting form was developed and used to record key information extracted from the
final set of included publications. Two reviewers (C.B.H. and M-K.W.) independently
recorded the following information from the included publications:
•

Author(s), year of publication, country of study

•

Aim of study

•

Population

•

Methodology

•

Name of relevant validated measure

2.3.1.5

Stage 5: Collating, summarizing and reporting results

We applied a directed approach to the qualitative content analysis of the text data for each
measure by collating,33 summarizing, and reporting the results in a way that provided a
narrative account of the data.28 Content analysis required analytical re-interpretation of the
25

items in the validated measures to determine whether they fit with the core concept of
illness perception and behaviour. The four components defined above were used as key
categories for coding the content of each measure.33 Particular attention was placed on
identifying any gaps in the measurement of illness perception and behaviour within the
target population. We have provided a summary of the included measures. Inter-rater
agreement when coding the measures to each component of illness perception and
behaviour was calculated using the kappa statistic. Statistically significant (P < 0.05) values
of kappa from 0.21 to 0.40, 0.41 to 0.60, and 0.61 to 0.80 were interpreted as fair, moderate,
and substantial agreement between raters, respectively.34

2.3.1.6

Stage 6: Consultation exercise

After the first draft of the manuscript, we sought two experts’ opinion to inform and
validate our findings.28 We had two consulting researchers: a clinician researcher (A.M.D.)
who focuses on OA, measurement, and rehabilitation – particularly related to the
experiences of people with early-to-moderate symptoms who are looking to manage and
prevent progression; and, a researcher (M.A.M.G.) with a health psychology background in
chronic disease, coping and measurement. They reviewed the initial draft of this
manuscript, provided insightful critiques and recommendations, and were involved from the
preparation of the manuscript through to the final draft submitted for publication.27
After the initial consultation, we performed a second search on April 19, 2015 using the
terms listed in Box 2.3. Two key journals were hand-searched: Health Psychology and
Journal of Behavioural Medicine. Also, given the new insights from the consultation, the
full-text results from before the consultation were rescreened for additional publications and
measures.
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Box 2.3 Search Strategy for identifying studies after consultation
•

Databases (inception to April 19, 2015)

AMED, CINAHL, Cochrane Library, EMBASE, Health and Psychosocial
Instruments, Open Grey, ProQuest Research Library (all 65 databases), PubMed, and
Web of Knowledge
•

Search terms

Search Terms: [Illness perception and behaviour related terms: “informal
support” OR “support seeking” OR “formal support” OR “illness perceptions” OR
“pain perceptions” OR “psychosocial perceptions” OR “health perceptions” OR
“illness appraisals” OR “illness evaluations” OR “pain appraisals” OR “illness
evaluations” OR “pain appraisals” OR “pain evaluations” OR “illness monitoring”
OR “pain monitoring” OR “illness support” OR “adaptation” OR “pain vigilance”
OR “illness vigilance”] AND [Knee related terms: “knee” OR “knee joint” OR
“patellofemoral joint” OR “tibiofemoral”] AND [The condition related terms:
“pain” OR “knee symptoms” OR “osteoarthritis” OR “knee osteoarthritis”] NOT
[“qualitative]. Where possible the search limits included English Language and
Human.
•

•

Journals (Inception to April 24, 2015)
•

Health Psychology

•

Journal of Behavioural Medicine

Rescreened full-text results obtained before consultation
n = 79
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2.4
2.4.1

Results
Data synthesis

Figure 2.1 outlines the data selection process. The searches before the consultation
produced 8028 publications, with 6534 publications remaining after the removal of
duplicates. Subsequently, 6455 publications that were ineligible were excluded prior to the
full-text review. The main reasons for excluding a publication after screening only its title
and abstract were that the publication was: an animal study, not written in English, a
conference abstract, a study of a post-surgical population, a study involving an excluded
disease, not related to knee pain or knee OA, a publication without a measure of the
concept, a qualitative study, or a review paper. The searches after consultation produced
4995 publications, and subsequently 4617 publications without duplicates. The full-text of
79 publications (before consultation) and 74 additional publications (after consultation),
totaling 153 publications were screened, of which 71 publications and their relevant
validated measures had their information charted and analysed.
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Figure 2.11 Flow chart of study inclusion and exclusion
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2.4.2

Components of illness perception and behaviour in each
measure

Table 2.1 shows the 16 validated measures identified in publications between 1987 and
2014. Eleven measures were identified before consultation and five after consultation. The
components of these 16 measures are presented in Table 2.1. We included multiple versions
or factor structures of some measures, for example the Coping Strategies Questionnaire
(CSQ), see Table 2.2 that presents a summary of the measures and how they were used. For
other measures, we included only the subscales used in the included publications, such as
only the religious coping subscale of the Coping Orientation to Problems Experienced
(COPE) inventory.35,36
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Table 2.1 Sixteen validated measures that capture components of illness perception and behaviour.

Illness Perception and Behaviour Components
Validated measure*

Arthritis Self-Efficacy Scale (ASES)

Monitor
Body

†

Define &
Interpret
Symptoms

Take
Remedial
Action

Utilize
Sources
of Help

x

Chronic Pain Coping Inventory (CPCI)
x

x

Summary of
Population

Number of Articles
and Study
Locations

Painful
early/advance
knee OA,
hip/knee OA,
non-acute
hip/knee pain,
OA-like knee
pain

n=29 (2=Canada,
2=Denmark,
2=Netherland,
1=Taiwan, 20=US,
1=Australia/Canada
/US )

Painful
hip/knee OA

Coping Orientation to Problems
Experienced (COPE) inventory†

Publications

Index
Article
of
measure

66, 70, 79-104

38

105

39

36

35

36

40

n=1 (1=US)

n=1
x

- Religious coping subscale

Knee OA
(1=US)

n=1
Coping Strategies Inventory (CSI)

x

x

x

Knee OA
(1=US)

Coping Strategies Questionnaire
(CSQ)†

x

x

Hand/hip/knee
OA, painful
knee OA,
painful
advance knee
OA, hip/knee

n=24

51, 70, 71, 74, 79,
83, 84, 86-88, 95,

(1=Spain, 1=UK,
21=US,
1=Australia/Canada

97, 101, 102, 104,

41

106-114

31

Daily Coping Inventory (DCI)

Fear Avoidance Beliefs Questionnaire
‡
(FABQ)

x

x

x

OA

/US)

Knee OA,
hand/hip/knee
OA

n=4
108, 109, 115, 116

42

59, 76, 117, 118

43

(4=US)

n=4
x

x

Knee OA,
hip/knee OA

-physical activity subscale

(3=Netherlands,
1=US)

51, 52, 95, 104,

Keefe’s Pain Behavior Observation
Protocol (Keefe’s method)†

x

Knee Osteoarthritis Fears and Beliefs
Questionnaire (KOFBeQ)†

x

Knee OA,
hip/knee OA

Knee OA

n=12

106, 110, 111, 117120

51, 60

50

50

121, 122

44, 45

(7=US)

n=1(1=France)
n=2

Illness Perceptions Questionnaire (IPQ)

Pain Catastrophizing Scale (PCS)

x

x

x

Knee pain,
hip/knee
pain/OA

Knee OA,
Severe knee
OA, advance
hip/knee OA

(1=Netherlands,
1=UK)

n=8 (1=Canada,
1=Japan, 6=US)

100, 115, 116, 123126

46

32

Pain-Coping Inventory (PCI)†

x

x

Pain Behaviors for Osteoarthritis
Instrument for Cognitively Impaired
Elders (PBOICIE)†

Questionnaire to Identify Knee
Symptoms (QuIKS)†

Survey of Pain Attitudes (SOPA)-35

Early painful
knee OA, hip/
knee OA, OArelated knee/
hip symptoms

x

n=12
(1=France,
10=Netherlands,
1=Nigeria)

76, 117, 127-136

47

52

52

37, 137

37

66

48

138

13, 49

n=1
x

Knee/hip OA
(1=US)

x

x

x

x

OA-like knee
pain

n=2
(2=Canada)
n=1

x

x

x

Knee OA
(1=Taiwan)

-Control Subscale

n=1
Ways of Coping Scale (WAYS)

x

x

x

Knee pain

(1=Canada)

* The measures are listed in alphabetical order.
† Measure that have been validated in the target population. A brief 6-item version of the ASES has been validated in the target sample.

‡ Only the subscales indicated were charted for each of these measures.
Note: All the self-report questionnaires except the DCI, PBOICIE and QuIKS have been translated and/or validated in languages other than English.
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As depicted in Figure 2.2, the coding of the items in the measures indicates that monitor
body was represented in 5 (31%) of the 16 measures, and define and interpret symptoms in
11 (69%), take remedial action in 12 (75%) and utilize sources of help in 5 (31%). Of the
16 measures, only the QuIKS included all four components of illness perception and
behaviour.37
The inter-rater agreement for the coding of the items in the validated measures included
before consultation were: a kappa of 0.43 for utilize sources of help, 0.51 for take remedial
action, 0.56 for monitor body and 0.68 for define and interpret symptoms. The consensus
discussion resulted in complete agreement between the two reviewers.

34

Number of Measures

16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
0

75%
69%

31%

31%

Monitor body

Define & interpret
symptoms

Take remedial
action

Utilize sources of
help

Component of Illness Perception and Behaviour

Figure 2.2 Chart showing the frequency of the four components of illness perception
and behaviour among the charted validated measures as used in the publications.
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2.4.3

Measures identified

The measures identified were originally developed to measure illness beliefs, coping
strategies/skills/styles, pain behaviour, or self-efficacy. The measures vary in length, and
are self-administered questionnaires,35,37-50 except for two that are observation-based.51,52
Most have been used many times to assess general and condition-specific populations and
have been validated over many versions and in many languages, but further details are
beyond the scope of this study. Table 2.2 provides a summary of the publications that used
the identified measures. Below is a brief description of each measure, listed in alphabetical
order.
The Arthritis Self-Efficacy Scale (ASES) is a 20-item 3-subscale (pain, function, and other
symptoms) self-report questionnaire.38 It was developed in the US in 1987 to evaluate the
beliefs individuals with arthritis have about their ability to cope with the consequences of
chronic arthritis.38 Its initial psychometric validation used attendees of an arthritis selfmanagement course.38 We coded the ASES as capturing the define and interpret symptoms
component.
The Chronic Pain Coping Inventory (CPCI) was developed in the US in 1995.39 It was
validated as a measure of behavioural coping strategies (illness-focus, wellness-focus, and
other) that could be addressed in multidisciplinary treatment pain programs using people
with chronic pain problems.39 Two versions were developed: a patient self-report version
(65 items) and a significant-other observation version (52 items).39 The patient version has
11 dimensions (guarding, resting, asking for assistance, relaxation, task persistence,
exercise/stretch, seeking social support, coping self-statements, opioid medication use, nonsteroidal use, and sedative-hypnotic use).53 The significant-other version lacks the
dimension for coping self-statements.53 After excluding item 65, which covers three
dimensions of medication use, the CPCI retained eight subscales.53 The psychometric
properties of this 8-subscale version have been further validated in studies using samples of
people attending multidisciplinary pain treatment programs.54-56 We coded the measure as
take remedial action and utilize sources of help.
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The COPE inventory is a 60-item 14-subscale self-report questionnaire about coping
strategies and styles.35 Its theoretical underpinning are a behavioural self-regulation as well
as Lazarus’ model of stress.35,42 The COPE was initially developed and validated in the US
in 1989 using samples of undergraduate students.42 Its 14 subscales are: active coping,
planning, suppression of competing activities, restraint coping, seeking social supportinstrumental, seeking social support-emotional, positive reinterpretation and growth,
acceptance, turning to religion, focus on and venting of emotion, denial, behavioural
disengagement, and alcohol-drug disengagement.35 Thirteen of its scales measure emotionfocused, problem-focused, and dysfunctional coping responses.35 The present review coded
the COPE religious coping subscale as take remedial action.
The Coping Strategies Inventory (CSI) is a 72-item 14-subscale self-report questionnaire
about coping strategies. It was developed and validated in the US in 1985 using samples of
undergraduate students.40,57 Its 14 subscales are arranged hierarchically into eight primary
factors (problem solving, cognitive restructuring, express emotion, social support, problem
avoidance, wishful thinking, self-criticism, and social withdrawal), four secondary factors
(problem- and emotion-focus engagement and problem- and emotion-focus disengagement)
that capture problem/emotion-focus coping and two tertiary factors (engagement and
disengagement) that capture approach/avoidance coping.40 Twenty-three of its items are
from the Ways of Coping Scale (WAYS).13,57 The CSI was coded as capturing all the
components except monitor body.
The CSQ is a 48-item questionnaire that records cognitive and behavioural coping
strategies.41 Its original version divided the items into three factors (cognitive coping and
suppression, helplessness, and diverting attention and praying).41 It was developed in the
US in 1983 using data from 61 subjects with chronic low back pain.41 The majority of CSQ
items were coded as take remedial action, and a few were coded as define and interpret
symptoms.
The Daily Coping Inventory (DCI) is a self-report questionnaire consisting of eight singleitem categories about coping.42 The DCI has an open item asking the respondent to state
their ‘most bothersome event or issue of the day’ and eight closed appraisal items.42 It was
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developed in the US in 1984 using samples of people in the local community to measure
cognitive and behavioural coping.42 In 1992, the DCI was adapted for assessing daily
coping with chronic pain in seven categories: distraction, redefinition, direction action,
relaxation, emotional expression, seek spiritual comfort, and seek emotional comfort.58 This
newer version of the DCI attained construct validation using 75 adults with rheumatoid
arthritis.58 We coded the DCI with all the components except monitor body.
The Fear Avoidance Beliefs Questionnaire (FABQ) is a 16-item 2-subscale (physical
activity and work) self-report questionnaire. It was developed in Scotland in 1993, and is
based on theories of fear behaviour, avoidance behaviour, and illness behaviour.43 Its
psychometric properties were validated using patients with lower back pain and/or sciatica
in a study of how one’s beliefs affect one’s physical activity and work.43 It has since been
adapted for knee pathology.59 Only the ‘physical activity’ subscale of the FABQ was
included and was coded as monitor body and utilize sources of help.
The Illness Perception Question (IPQ) is a 38-item 5-subscale self-report questionnaire.45 It
was theoretically-based on Leventhal’s self-regulation model of illness behaviour and was
constructed to assess the five cognitive attributes of illness representation.16,22,45 It was
developed in England and New Zealand in 1994 and was validated using samples of
patients in England with diabetes, rheumatoid arthritis, asthma or undergoing dialysis, and
patients in New Zealand with chronic fatigue syndrome, chronic pain, or myocardial
infarction.45 Only some samples were used for evaluating each psychometric property.45 To
correct minor psychometric problems in two subscales and add additional subscales which
would also cover emotional representation, a revised version (IPQ-R) was developed in
2002 using eight different illness groups.44 The IPQ-R consists of three sections. We
included section two, which is a 38-item 7-dimension measure of timeline acute/chronic,
timeline cyclical, consequences, personal control, treatment control, illness coherence, and
emotional representations.44 We coded section two as monitor body and define and interpret
symptoms.
Keefe’s Pain Behavior Observation Protocol (Keefe’s method) is a 5-item observationbased measure.60 It was developed and validated in the US in 1982 using a sample of
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patients with back pain.60 In the original measure, people were asked to sit, recline, stand,
walk, and shift, and the frequency of five concomitant behaviours were coded as pain
behaviour items. For assessing people with knee OA pain, the five items were modified to
guarding, active rubbing, unloading joints, rigidity, and joint-flexing.51 We coded all five
items as take remedial action.51
The Knee Osteoarthritis Fears and Beliefs Questionnaire (KOFBeQ) is an 11-item selfreport questionnaire that assesses an individual’s fears and beliefs about their knee OA.50 It
was developed in 2013 in France using an empirical approach.50 Its psychometric properties
were tested using a sample of 524 patients with radiographic knee OA.50 We coded the
KOFBeQ as define and interpret symptoms.
The Pain Behaviors for Osteoarthritis Instrument for Cognitively Impaired Elderly
(PBOICIE) is a 6-item observation-based measure.52 It was developed and validated in the
US in 2008 and uses the activity protocol from the Keefe’s method but applies a different
set of 6 items (excessive stiffness of the affected joint during activities other than walking,
shifting weight when seated, massaging affected area, clutching or holding onto affected
area, rigid and tense body posture, and clenching teeth).51,52 A 10-item version was
evaluated in a sample of 32 non-cognitively impaired elderly with knee or hip OA, which
resulted in the 6-item PBOICIE.52 We coded the PBOICIE as take remedial action.
The Pain Catastrophizing Scale (PCS) is a 13-item 3-subscale (rumination, magnification,
and helplessness) self-report questionnaire about exaggerated negative affect towards
pain.46, 61 It was developed in Canada in 1995 for clinical and non-clinical populations and
includes five items from the catastrophizing subscale of the CSQ.41,46,62 It was initially
validated in a series of four studies, of which three used samples of undergraduate students
and the other used a sample of people undergoing an electro-diagnostic evaluation.46 Its
psychometric properties were then confirmed using a sample of undergraduate students.63
The PCS was coded as define and interpret symptoms.
The Pain-Coping Inventory (PCI) is a 33-item self-report questionnaire that records
individuals’ cognitive and behavioural pain coping strategies.47,64 The original paper on its
development was a 1996 publication from the Netherlands and is not available in English.47
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A follow-up publication in 2003 confirmed its psychometric properties using patients with
chronic pain conditions.64 The conditions specified were rheumatoid arthritis, fibromyalgia,
and several location-specific pain syndromes, although they are not specific to the knee.64
The PCI has two second-order factors that cover six first-order factors: active pain coping
(transformation, distraction, and reducing demands) and passive pain coping (retreating,
worrying, and resting).47,64 The items of the PCI, similar to the CSQ, were predominantly
coded as capturing take remedial action. The PCI also had a few items coded as monitor
body and define and interpret symptoms.
The QuIKS is a 13-item 4-subscale self-report questionnaire focused on identifying early
symptomatic knee OA problems in order to inform conservative intervention.37 It was
developed in Canada, in 2013, using an empirical approach.37 It demonstrated internal
consistency in a sample of people between 40 and 65 years of age with knee pain consistent
with knee OA.37 Its four subscales are: medication [use], monitoring [of knee symptoms],
interpreting [ongoing knee symptoms], and modifying [activities in response to knee pain].
The QuIKS was coded as having all four components of illness perception and behaviour.
The Survey of Pain Attitudes (SOPA) underwent preliminary development and
psychometric evaluation as a 24-item 5-subscale measure of pain-related beliefs in the US
in 1986.53 However, the development and validation of its original 57-item 7-subscale (pain
control, disability, harm, emotion, medication, solicitude, and medical cure) version was
informed by cognitive behavioural models and used 241 patients with chronic pain (17%
had lower extremity pain, but the knees were not specified).65 Subsequently, a 35-item
version (SOPA-35) was published in 1999.48 The SOPA-35 has the same seven subscales,
and was developed and underwent validation using patients with chronic pain in several
body locations, not specifying the knees.48 In the present review, we included only the
control subscale of the SOPA-35 which we coded as all the components except utilize
sources of help.48,66
The WAYS is a 66-item self-report questionnaire, whose theoretical underpinning is the
coping and stress theory, was developed by Lazarus and Folkman (1984) to record coping
and behaviour strategies.13,67 Only 50 items are used for scoring. Analyses using a sample
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of 150 community dwelling adults derived eight subscales: confrontive coping, distancing,
self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful
problem solving, and positive reappraisal.49 Most items were coded as take remedial
action, a few items were coded as define and interpret symptoms, and as utilize sources of
help (particularly, the items of the seeking social support subscale).
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Table 2.2 Summary of publications that used the identified measures

Author/

Country

Sample*

Aim/Question

Year

Clark et al.

Canada

105 OA-like knee

Develop QuIKS as a

pain

screening tool for

( 2014) 37

Golightly et al.

Relevant

Methodology

Measure-

validated

Variable

measure

Type

QuIKS

Cross-

Independent

sectional

Subscales have
adequate internal

early knee OA
US

Results

consistency

153 hand/hip/knee

Examine associations

OA (82=knee)

between pain coping

related to maximum

strategies and daily

pain and pain range

(2014) 108

DCI and CSQ

Longitudinal

Independent

Pain coping strategies

pain diary-based
measures

Hiramatsu et al.

Japan

12 knee OA, 11

Examine cerebral

healthy

responses to

sectional

catastrophizing (PCS)

experimental pain

(Case-control)

were significant

(2014) 123

PCS

Cross-

Independent

3 dimensions of

different between
groups.
Holla et al.
(2014) 130

Netherlands

828 painful early

Examine predictors

knee OA

and outcomes of

PCI

5-year
Longitudinal

Mediator

Knee pain/Vitality
predicted pain-related

avoidance of

avoidance of activity

activities using the

(PCI) which predicted
42

avoidance model
Marcum et al.

US

(2014) 79

activity limitations.

190 painful

Evaluate correlates of

ASES, CSQ

Cross-

advanced knee

gait speed

(catastrophizing

sectional

OA

Independent

Functional self-efficacy
(ASES) and opioid use

subscale)

were independently
associated with gait
speed.

Marks

US

17 knee OA,

Find factors

ASES (Pain and

Cross-

women

contributing to

Other symptoms

sectional

perceived impact of

subscales)

(2014) 80

Mediator

Pain efficacy (ASES)
mediated ambulatory
capacity

condition
Pisters et al.

Netherlands

288 hip/knee OA

Evaluate mediating

PCI (resting

5-year

(216 knees)

role of reduced

subscale)

Longitudinal

(2014) 128

Independent

Reduced knee extensor
muscle strength

muscle strength

mediated avoidance of

between avoidance of

activity (PCI) effect on

activity and

limitations

limitations
Rayahin et al.

US

212 knee OA

Which psychosocial

ASES and PCS

factors were each
(2014) 81

Skou et al.

Denmark

2-year

Independent

Longitudinal

Higher self-efficacy
(ASES) and pain

associated with good

catastrophizing(PCS)

pain experience

were associated with

outcome?

good outcome

79 non-acute

Identify predictors of

hip/knee pain

effectiveness of

ASES

1-year
Longitudinal

Independent

Self-efficacy predicted
pain and quality of life.
43

education and
(2014) 82

Smink et al.
(2014)

exercise
Netherlands

132

Wideman et al.

US

313 painful

Which factors relate

hip/knee OA

to health care use

107 knee OA

PCI

Independent

Longitudinal

Active coping style
(PCI) determinant of

after stepped-care

health care use, but not

strategy?

statistically significant

Does sensitivity to

PCS

physical activity
(2014) 124

36-week

Cross-

Dependent

Along with other

sectional

(Outcome)

variables,

predicts

catastrophizing (PCS)

psychological factors,

predicted walking

response to

performance, self-

quantitative sensory

reported pain and

testing, and OA-

physical function

related outcomes?
Alschuler et al.

US

797 painful knee

Are pain coping skills

OA

prognostic factor of

(2013) 71

CSQ

1-year

Independent

Constructs in CSQ were

Longitudinal

(Predictor)

prognostic of pain and

pain/function

function

changes?
Benhamou et al.
(2013)

France

524 knee OA

50

Develop measure of

KOFBeQ

fears and beliefs held

Cross-

Independent

sectional

Reliable, and obtained
content and construct

by patients with knee

validation

OA
Bolaji et al.

Nigeria

215 painful

Explore difference in

PCI

Cross-

Dependent

Passive coping (PCI)
44

(2013) 133

hip/knee OA (83

pain coping strategies

knees, 71 both)

between genders

sectional

was higher in males,
and related to poorer
pain, depression, and
physical activity

Cruz-Almeida et

US

194 knee OA

Identify psychology

CSQ

profile relationship

al.

Cross-

Dependent

sectional

dimension of CSQ

with pain and sensory

related to higher

(2013) 114

Hamilton et al.

Lower scores on passive

optimism
Canada

105 knee pain

(2013) 137

Does activity-

QuIKS

Cross-

modifying behavior

(Modifying

sectional

mediates the

subscale)

Mediator

activity-modifying
behavior (QuIKS)
mediated pain severity

relationship between

effect on physical

the pain severity with

function and quality of

physical function or

life

knee-related quality
of life?
Hunt et al.

Canada/US/
Australia

(2013) 83

20 knee OA

Feasibility of a

CSQ, ASES

Intervention

Dependent

Exercise with but not

physiotherapist-

(Randomized

without Pain Coping

delivered treatment

Control Trial)

Skills Training

protocol combining

improves pain coping

exercise and Pain

(CSQ). Both improved

Coping Skills

self-efficacy (ASES) for

Training

control of pain
management

45

Riddle and

US

Jensen

873 painful knee

Does the two-item

CSQ (2-item per

Cross-

OA

per subscale version

subscale

sectional

of CSQ

version)

(2013) 107

Independent

Construct validity was
generally supported
(strongest for

have construct

Catastrophizing and

validity?

Praying and Hoping
subscales), criterion
validity depended on
criterion

Weiner et al.

US

(2013) 84

190 painful

What is the efficacy

ASES, CSQ

Intervention

Independent

advanced knee

of periosteal

(catastrophizing

(Randomized

(ASES), depressive

OA

stimulation as a

subscale)

Control Trial)

symptoms, higher

treatment?

Lower self-efficacy

difficulty with daily
activity predicted lower
likelihood of response

Holla et al.

Netherlands

151 painful early

Is the avoidance

knee OA

model valid?

PCI

Cross-

Mediator

sectional

Avoidance (PCI)
mediated pain /negative

(2012) 127

affect effect on lower
muscle strength.
Avoidance predicted
activity limitations.

Murphy et al.

US

44 painful

Evaluate how coping

hip/knee OA

strategies relate to

CPCI

Crosssectional

Moderator

Guarding (CPCI)
related to lower levels
46

(2012) 105

symptoms and

of activity. Asking for

physical activity

Assistance (CPCI)

patterns

related to higher levels
of activity. Resting
(CPCI) moderated
pain’s association with
activity. Guarding,
Resting, Task
Persistence, and Pacing
(CPCI) moderated
fatigue’s association
with activity

Pisters et al.

Netherlands

288 hip/knee OA

Describe the course

PCI (resting

5-year

(216 knees)

of limitations in

subscale)

Longitudinal

(2012) 131

Independent

Avoidance of activities
predicted future activity
limitations

activities over 5 years
of follow-up and
identify predictors of
future limitations in
activities

Skou et al.

Denmark

36 hip/knee OA-

Feasibility of early

related pain

multimodal non-

(2012) 85

Somers et al.

ASES

3-month

Dependent

Longitudinal

Significant
improvement on ASES

surgical treatment
US

232 knee OA,

Efficacy of pain

ASES and CSQ

Intervention

overweight/obese

coping skills training

(catastrophizing

(Randomized

Dependent

Significant difference in
improvements in self-

(2012) 86
47

and lifestyle

subscale)

Control Trial)

ASES and CSQ

Cross-

efficacy between groups

behavioral weight
management
interventions
Broderick et al.

US

171 painful

What are the

hip/knee OA

predictors of

(2011) 70

Independent

sectional

Better adaptive coping
(CSQ) associated with

treatment

better self-efficacy

expectation?

(ASES), quality of life,
and psychological
function

Van Dijk et al.

Netherlands

237 hip/knee OA

Do psychological and

(174=knee)

social factors predict

predictor of activity

activity limitations?

limitations

(2011) 129

Wade et al.

US

310 severe knee

What is the

OA

relationship between

(2011) 125

PCI

PCS

Longitudinal

Cross-

Independent

Mediator

sectional

Not independent

Pain catastrophizing
(PSC) mediated pain

pain catastrophizing

unpleasantness effect on

and 3-stage model of

suffering

pain processing?
Wu et al.

Taiwan

205 knee OA

(2011) 66

Effectiveness of a

ASES and

Intervention

Dependent

self-management

SOPA-35 (pain

(Treatment-

and self-efficacy

program

control

Control Trial)

(ASES) improved by

subscale)
Gandhi et al.

Canada

200 advance

Impact of mental

PCS

Pain beliefs (SOPA-35)

program
Cross-

Independent

Pain catastrophizing
48

(2010) 126

hip/knee OA

health symptoms and

sectional

(PSC) predicted lower

catastrophizing on

function, quality of life,

scores of function,

and pain

quality of life, and
pain
Holla et al.
(2010)

Netherlands

134

1002 early OA-

Predict 2-year course

related knee/hip

of activity limitations

PCI

2-year

Independent

Longitudinal

Pain coping strategy
(PCI) associated with

symptoms

higher activity
limitations

Izal et al.

Spain

104 OA (61.5%

Role of coping

knee)

strategies in

(2010) 74

CSQ

Cross-

Moderator

sectional

Certain pain coping
strategies (CSQ)

disagreement

explain disparity

between radiographic

between joint damage

damage and function

and functional
impairment

Mcknight et al.
(2010)

US

87

254 early knee

Effect of coping self-

ASES and CSQ

9-month

ASES=Medi

Self-efficacy (ASES)

OA

efficacy and

(catastrophizing

Longitudinal

ator,

mediated pain

catastrophizing on

subscale)

CSQ=Indepe

catastrophizing (PCS)

ndent

effect on physical

physical function

function
Peat and
Thomas
(2009)

139

UK

285 knee pain

Describe the changes

CSQ (1 item per

18-month

Worsen of pain was

of appraisal and

subscale

Longitudinal

accompanied by

behavior that

version)

accompanies

increased
catastrophizing, praying
49

worsening of knee

and hoping (CSQ), pain

pain

frequency/extent,
depressive symptoms,
medication use, and
functional limitations

Scopaz et al.

US

182 knee OA

(2009) 118

Jones et al.

UK

939 hip/knee OA

(2008) 88

Are psychological

FABQ (physical

Cross-

variables associated

activity

sectional

with physical

subscale) and

anxiety related to poorer

function?

Keefe's method

physical function

Examine the

ASES (pain

Cross-

relationship between

self-efficacy and

sectional

race and pain coping

function self-

but not self-efficacy

strategies

efficacy

(ASES)

Independent

Higher fear avoidance
beliefs (FABQ) and

Dependent

Race associated with
hope and praying (CSQ)

subscales) and
CSQ
Perrot et al.
(2008)

France

135

4,719 hip/knee

Study pain coping

PCI

Cross-

Dependent

OA (2781=knee,

strategies, and

385 = both)

evaluate the French

OA. Supported

version PCI

structural and other

sectional

More passive coping
with longer duration of

validation criteria of
PCI
Shelby et al.

US

192 knee OA

Does self-efficacy
mediate pain

(2008) 100

catastrophizing effect

ASES, PCS

Cross-

ASES=

sectional

Self-efficacy was a
significant mediator

Mediator
50

on pain and

PCS=

disability?
Independent
Somers et al.

US

(2008) 113

43 painful knee

Does pain

CSQ

Cross-

OA, borderline

catastrophizing relate

(catastrophizing

sectional

morbidly/morbidl

to pain and

subscale)

y obese

adjustment?

Dependent

Higher pain
catastrophizing (CSQ)
associated with less
pain, higher binge
eating, and lower eating
self-efficacy.

Tsai et al.
(2008)

US

52

7 cognitively

Develop and do

Keefe's method,

Cross-

impaired elder,

psychometric testing

PBOICIE

sectional

then 32 elders

of PBOICIE

Dependent

PBOICE significantly
associated with Keefe's
method, discriminate

with hip/knee OA

pain behaviors before
and after analgesic use.
Internal consistency not
acceptable

Wright et al.
(2008)

US

89

275 early knee

Which psychological

OA

factors with disease

ASES

24-month

Mediator

Longitudinal

Higher self-efficacy
mediated resilience

severity factors best

effect on lower pain and

account for levels of

better physical function

pain and function?
Fraenkel et al.
(2007)

140

US

105 OA-like knee

Efficacy of a

pain

computer tool to

(Randomized

improve informed

Control Trial)

ASES

Intervention

Dependent

Self-efficacy (ASES)
higher with intervention

51

decision-making
Maly et al.
(2007)

Canada

54 knee OA

90

Does self-efficacy

ASES (function

Cross-

mediate the effect of

subscale)

sectional

Mediator

Self-efficacy (ASES)
mediated age and

age, psychosocial,

strength but not

impairment, and

depressive symptoms

mechanical factors on

and obesity on walking

walking

impairment

performance?
Marks

US

100 painful knee

Examine strength of

OA

the relationship

(2007) 91

Botha-

Netherlands

Scheepers et al.

ASES

Cross-

Independent

sectional

associated with lower

between walking

pain, exertion during

ability and certain

walking, and depression

psychological factors

scores

316 hip/knee

Is the association

IPQ (revised

Cross-

pain/OA

between impairments

version IPQ-R)

sectional

Moderator

Construct in IPQ-R had
modifying effect on the

and activity
(2006) 122

Higher self-efficacy

association

limitations modified
by illness perception
and mental health?

Emery et al.
(2006)

116

US

62 knee OA

Relationship between
baseline pain coping

DCI and PCS

Crosssectional

Independent

Higher pain
catastrophizing (PCS)

and pain

predicted lower state

catastrophizing on

anxiety

changes in
52

nociceptive threshold,
pain rating, and
anxiety following
coping skills training
Maly et al.
(2006)

Canada

54 knee OA

99

Determine factors

ASES (Function

Cross-

related to self-

subscale)

sectional

Dependent

51 % of variance in
functional self-efficacy

efficacy for physical

(ASES) explained by

task

knee stiffness,
hamstrings strength,
age, depression scores,
but by not pain, anxiety,
joint space, and body
weight.

Mitchell et al.
(2006)

UK

231 knee pain

121

Investigate treatment

IPQ

of knee pain in

Cross-

Independent

sectional

Illness beliefs (IPQ)
predicted consultation

primary care

with GP and referral to
rheumatology services

Heuts et al.
(2005)

Netherlands

273 hip/knee OA

92

Efficacy of self-

ASES (Function

Intervention

management program

subscale)

(Randomized

(ASES) improvement

Control Trial)

not significantly

Dependent

Functional self-efficacy

different between
groups
France et al.
(2004)

115

US

74 post-

Relationship between

menopausal

pain behavior,

DCI, PCS

Crosssectional

Independent

More emotion-focus
coping (DCI) or pain
53

women knee OA

hormone replacement

catastrophizing (PSC)

and 58 aged-

therapy, and pain

related to more arthritis

match men

pain and less pain
tolerance

Harrison
(2004)

US

50 knee OA

93

Keefe et al.
(2004a)

US

109

Relationship among

ASES (function

Cross-

knee OA grade, pain,

subscale)

sectional

Independent

Self-efficacy and pain
accounted for 74% of

balance, and self-

variance in functional

efficacy

difficulty

64 women and 36

Gender difference in

CSQ

30-day

men with knee

pain, mood, and pain

(catastrophizing

Longitudinal

OA

coping

subscale and

Dependent

Problem-focus coping
(DCI) used more by
women.

coping efficacy
subscale) and
DCI
Keefe et al.
(2004b)

US

101

72 married

Test separate and

patients with

combined effects of

improve pain coping

painful knee OA

spouse-assisted pain

(CSQ) and self-efficacy

and their spouse

coping skills training

(ASES)

ASES and CSQ

Intervention

Dependent

Combined interventions

and exercise training
Jensen et al.
(2003)

102

US

87 knee OA

Develop and validate

(from Keefe et al.

brief versions of

(Randomized

related belief (ASES)

pain-related beliefs

Control Trial)

and coping strategies

1996)

104

and coping scales

ASES and CSQ

Intervention

Dependent

Brief versions of pain-

(CSQ) developed and
validated.
54

Sharma et al.
(2003)

US

257 knee OA

103

Identify factors that

ASES (function

3-year

predict poor physical

subscale)

Longitudinal

Independent

Self-efficacy along with
other variables

function

protected against poor
physical function scores

Gaines et al.

US

43 knee OA

Determine

ASES

relationship between
(2002) 94

Cross-

Dependent

sectional

Relationship between
self-efficacy and

arthritis self-efficacy

function vary by gender

and self-reported
functional
performance
Steultjens et al.

Netherlands

190 hip/knee OA

Role of coping styles

FABQ (physical

36-week

(119 Knee OA)

as prospective

activity

Longitudinal

determinants of pain

subscale) and

predicted disability at

and disability

PCI

follow-up, and pain

(2001) 76

Independent

For knee OA, only
resting (PCI) at baseline

transformation (PCI)
was determinant of
pain. For hip, none
significant.
Hopman-Rock

Netherlands

et al.

56 knee/hip OA,

Evaluate self-

49 controls

management program

ASES

Intervention

Dependent

(Control Trial)

Self-efficacy (ASES)
significantly related
group x time effect

(2000) 98
Rapp et al.

US

394 knee pain

Evaluate relationship

CSQ

Cross-

Independent

Pain coping skills
55

between pain coping
(2000) 112

sectional

(CSQ) significantly

skills and disability

associated with physical
disability

Keefe et al.

US

88 painful knee

Determine long-term

ASES, CSQ,

OA

effect of spouse-

Keefe's method

(1999) 95

Intervention

Independent/

Improved self-efficacy
and coping at 6 months.

Dependent

assisted pain-coping

Improved self-efficacy

skills training on

and pain behavior at 12

several physical and

months

psychological
disability, paincoping and pain
behavior
Hopman-Rock

Netherlands

and Kraaimaat

157 knee/hip pain

Investigate use of

in last month

pain coping strategies

(1998) 136

PCI

Cross-

Mediator

sectional

Pain coping (PCI)
mediated pain

by community-living

chronicity effect on

elderly with hip/knee

physical disability

pain
Sullivan et al.

US

92 painful knee

Are gains in function

ASES (pain and

Intervention

OA

over 8-weeks

other symptoms

(Treatment-

were not significant

sustained at 1 year

subscales)

Control)

between groups

Determine

FABQ (physical

Intervention

effectiveness of

activity

(Randomized

between intervention

exercise therapy

subscale)

Control Trial)

and control

(1998) 96

Dependent

Gains on both subscales

follow-up?
van Baar et al.
(1998) 59

Netherlands

201 hip/knee OA

Dependent

Scores not different

56

Van Baar et al.

Netherlands

200 knee/hip OA

Examine the extent to

FABQ (physical

Cross-

FABQ and

Retreating (PCI)

(112=knees)

which various factors

activity

sectional

PCI=

predicted pain

affect pain and

subscale),

Independent

disability

Keefe's method,

Keefe's

and PCI

Method=

(1998) 117

Dependent
Keefe et al.

US

130 knee OA

Examine relationship

ASES and CSQ

between pain coping
(1997) 97

Cross-

CSQ=

sectional

strategies predicted
Independent

strategies and self-

ASES=

efficacy

Different coping

lower/higher selfefficacy

Dependent
Keefe et al.

US

88 knee OA

(1996) 104

Determine the effect

ASES, CSQ,

of spouse-assisted

Keefe's method

Intervention

Dependent

Improved psychological
disability scores, self-

pain-coping skills

efficacy and certain

training several

copings strategies

physical and
psychological
disability, paincoping and pain
behavior
Blalock et al.
(1995)

36

US

300 knee OA

Is there a relationship
between coping
strategies and future

COPE and CSI

6-month
Longitudinal

Independent

Constructs in CSI were
related to future
psychological well57

well-being?
Fry and Wong

Canada

69 knee pain

Determine the effect

being
WAYS

of matching pain
(1991) 138

Cross-

Intervention

sectional

Matches between
coping styles (WAYS)

management training

with intervention types

and individual differ-

were effective

ences on coping style
Keefe et al.

US

99 knee OA

(1990a) 110

Does cognitive-

Keefe's method

Intervention

behavioral

and CSQ

(Randomized

training had improved

Control Trial)

pain and psychological

intervention to

Independent

improve pain coping

Pain-coping skills

disability scores

skills reduce pain,
physical and
psychological
disability, and pain
behavior?
Keefe et al.

US

99 knee OA

(1990b) 111

6 months follow-up

Keefe's method

Intervention

of pain-coping skills

and CSQ

(Randomized

psychology ability, and

Control Trial)

trend towards

training

Independent

Deterioration in gains in

improvement in
physical ability
Keefe et al.
(1987a)

51

US

87 painful knee

Provide descriptive

Keefe's method

Cross-

OA

data on behavior

and CSQ

sectional

Independent

Guarded movement
(Keefe's Protocol) was

patterns and

most frequent pain

functional

behavior. Pain control
58

impairment

and rational thinking
(CSQ) were predictive
of functional
impairment

Keefe et al.
(1987b)

106

US

51 painful knee

Determine the

OA

relationship between

CSQ

Crosssectional

Independent

Coping attempts, pain
control and rational

coping strategies and

thinking (CSQ)

pain, health status,

accounted for 60% of

and psychological

variance in CSQ scores.

distress

Higher pain control and
rational thinking
predicted better pain,
health status, and
psychological distress
scores.

*Most samples composed of older adults, usually aged ≥40 year or ≥50 years.
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2.5

Discussion

To our knowledge, this is the first attempt to identify and analyse the content of published
validated measures that can be interpreted as capturing components of illness perception
and behaviour in people who have knee pain/OA. The primary finding was that most
existing measures did not capture all four components of illness perception and
behaviour.37 The one that did, the QuIKS, was the most recently developed of all the
measures. The QuIKS is one of only seven measures identified in this review that have
been validated using people with knee pain/OA, see Table 2.1.37
Our findings demonstrated that most of the included measures do not operationalize all
four components of illness perception and behaviour. The validated measures focus more
on capturing take remedial action. This seems to be reflective of several measures
capturing cognitive and/or behavioural coping strategies, including the COPE, CPCI, CSQ,
CSI, DCI, and PCI.39-42,47 Conversely, only 31% of the measures were identified to have
items that capture monitor body or utilize sources of help. One could argue that utilize
sources of help is a very unique concept and that our search was aimed at support-seeking
rather than the support literature. However, other questionnaires fitting this concept did
come up in our search, but they did not have an individual-level scoring method,68 were
open-ended questions, were checklists, or were comprised of a single question about the
number of visits to a clinician.66,69
We included only one subscale from each of the COPE, FABQ and SOPA-35 because that
was the portion of these questionnaires used in the included publications. The other items
of these measures could be explored to determine how comprehensively each full measure
operationalizes the concept of illness perception and behaviour. The suitability of the full
version of these measures might vary with clinical scenarios, such as the temporal
dimensions of a person’s condition, and with the measurement purpose, such as for
diagnosis, evaluation, or prognosis. Therefore, future research could investigate the validity
of the full version of these measures for use in assessing people who have knee pain/OA.
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With respect to our findings, it can be reasoned that scores on validated measures that are
missing components of illness perception and behaviour provide an incomplete description
and insight into an individual’s response to his or her symptoms.18 The measures identified
have been previously demonstrated to be predictive of pain level, disability, activity
limitations, psychological functioning (e.g. depression) and physical functioning in the
target population.36,70,71 Particularly, the ASES and CSQ have been richly used in many
roles as independent, mediator, moderator, and dependent variables in studies on the target
population, see Table 2. A measure covering the four components may provide sufficient
information regarding a person’s response to their knee pain/OA to adequately inform
therapy.
While the QuIKS captures all four components, it has only undergone content validation
and had its internal consistency confirmed in people with early symptoms of knee OA.37
More aspects of validation are required to provide confidence that the QuIKS is
psychometrically sound and related to physical and psychological adjustments to knee
pain/OA. Alternatively, an additional measure capturing all four components of illness
perception and behaviour could be developed by combining items from some of the
included measures, and then validated for people with symptomatic knee OA.
The assessment of illness perception and behaviour is applicable to the recognition of
illness and the implementation of the medical management of disability.18,43,72 As noted by
Sirri et al. (2013: p.79), illness behaviour is a concept that delineates “prognosis and
therapeutic differences” among people with “deceptively” similar diagnoses.18 Therefore,
illness perception and behaviour may become important in explaining the discordance
between the pain symptoms and the biologic evidence of knee OA, such as was previously
demonstrated using the CSQ.18,73,74 For example, patients with similar structural knee joint
changes and pain levels may require different treatment approaches if their levels of illness
perception and behaviour are different.75 Identifying illness perception and behaviour
issues that clinicians should address, could help direct clinical resources such as patient
education and structured interventions to improve an individual’s health.18
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Caution is advised regarding the use of the identified measures in the target population
where they have not undergone validation. Many of the measures were developed and have
been validated in a sample that was not identified as including people with knee pain/OA.
For example some were developed and validated using samples of undergraduate
psychology students,35,46,64 general population from the community,49 and people with
various chronic conditions.39,53 Also, whilst measures validated in populations affected by
OA in other joints are likely applicable to knee OA, their psychometric properties might be
different for people with knee OA.76

2.6

Study limitations

This review has some limitations. First, given the large variety of terms related to illness
perception and behaviour, it is possible that relevant terms were missed. Therefore
validated measures used with the target population may have been overlooked. Also, two
measures were not included because they were not made available by the developer or
publisher by the end of this study.77,78 Second, the definitions used for each of the four
components of illness perception and behaviour were developed for this study.17 So, the
focus was on responses to illness and not all the different factors that may shape illness
responses (e.g., optimism and mastery). It is likely that there may be many more
components and antecedents to illness perception and behaviour, such as psychological
function (depression), anxiety and optimism. Alternate definitions could be considered for
the four components, which would possibly change the coding of the included measures.

2.7

Conclusions

Several validated measures capture the components of illness perception and behaviour
defined in this study, but most do not capture monitor body or utilize sources of help. Only
the QuIKS captures all four components. We recommend that it undergo further validation
of its psychometric properties in the target population.
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Chapter 3

3

Interval-level measure of illness perception and
behaviour

A version of this chapter is presently under review for publication in a peer-reviewed
journal.

3.1

Abstract

Objective: The Questionnaire to Identify Knee Symptoms (QuIKS) was recently
developed to promote activity by screening for key lived experiences (i.e., illness
perception and behavior) in people with osteoarthritis (OA) –like knee pain. The main
purpose of this study was to evaluate measurement properties of the QuIKS using Rasch
analysis in a sample of people with knee pain symptoms consistent with symptomatic knee
OA.
Methods: This study used cross-sectional data. The sample included 200 people along the
following knee health continuum: pain-free healthy knees (n=55) from a university
community, knee pain with no knee OA diagnosis (n=111) from a university-affiliated
medical clinic, and patients with surgeon-diagnosed symptomatic knee OA awaiting high
tibial osteotomy (n=34) from a sports medicine surgical clinic. The 13-item QuIKS was
evaluated for its factor structure, item- and person-fit, an item’s category response
structure, differential item functioning, local item dependency, unidimensionality, and test
precision. Subsequently, the QuIKS underwent known-groups analysis and convergent
validity with the Knee injury and Osteoarthritis Outcome Score (KOOS).
Results: In the QuIKS, each item’s category response structure was modified. Local item
dependency informed the formation of four testlets. This refined QuIKS obtained summary
fit to the Rasch model, unidimensionality, reliability (person separation index = 0.82) and
interval-level scoring. Subsequently, the Rasch-refined QuIKS (QuIKS-R) demonstrated
excellent known-groups validity and good convergent validity with the KOOS (Spearman’s
rho = 0.45-0.77).
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Conclusions: The QuIKS-R provides interval-level quantification of illness behavior in
people with knee pain symptoms consistent with symptomatic knee OA. Its scores may
help clinicians to identify important issues to address in therapy for people with early
symptoms of symptomatic knee OA.
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3.2

Introduction

Symptomatic knee OA is a chronic degenerative joint disease that leads to activity
limitations, performance restrictions, and reduced quality of life.1-4 In the US, the lifetime
risk of developing symptomatic knee OA is up to 23.9%, depending on one’s sex, age, and
obesity status.3 The lived experience of knee pain in people with knee OA is considered to
be a biopsychosocial phenomenon.4-8
Studies have linked illness perception and behaviour to knee OA-related disability in the
pre-diagnosis stage and early stages of knee OA, and in people with recently diagnosed
symptomatic knee OA.4-8 Illness perception and behaviour can be considered to have four
components, each component corresponding to a clause in the definition that follows.
Using Mechanic’s (1986) definition of illness behaviour, illness perception and behaviour
is defined as “the manner in which persons monitor their bodies, define and interpret their
symptoms, take remedial action, and utilize various sources of help as well as the more
formal health-care system”.9 Illness perception and behaviour is promoted as a health
construct.10, 11 When operationalized, it can identify issues that clinicians should address
with patients to facilitate management of symptoms.10, 11
Quantifying illness perception and behaviour, whether adaptive or maladaptive, may be
useful in facilitating early recognition and management of knee OA symptoms to aid in the
delay or prevention of long term disability. Several generic measures of illness perception
and behaviour exist.10, 11 These measures include the Illness Behavior Questionnaire,
Symptoms Response Scale, Scale for the Assessment of Illness Behavior, and Illness
Cognition Scale, to name just a few.11 No generic measure of illness perception and
behaviour has been specifically validated for knee pain and knee OA. Thus, their
application to knee pain problems is questionable. For example, the Illness Behavior
Questionnaire assesses several dimensions of abnormal illness behaviour and is currently
the most widely used of these measures.12, 13 While it has a strong focus on the affective
and cognitive aspects of illness, it overlooks overt aspects which are more applicable to
physical health management.10, 11 The concept of illness perception and behaviour has been
operationalized as coping strategies in other measures, such as the commonly used Coping
Strategies Questionnaire.10, 14 However, we searched the literature and found the measures
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of coping strategies are limited in their coverage across the four components (i.e., full
definition) of illness perception and behaviour. More specifically, these measures provide a
fairly incomplete picture of a patient’s illness perception and behaviour. This limitation in
these measures could affect a clinician’s ability to make an informed decision about the
management of a patient’s knee pain and knee OA-related symptoms. On the other hand,
the QuIKS was specifically developed for clinical use in assessing a patient’s responses to
their knee pain and knee OA-related symptoms.15 Furthermore, the contents of the QuIKS
covers all four components of illness perception and behaviour and could better identify
important issues to address in therapy.
The QuIKS is a 13-item self-administered discriminative questionnaire.15 It was developed
using a mixed-methods approach, which aligns with recommendations by Velozo et al.
(2012) for scale development.16 First, its items were generated through grounded theory
qualitative research using one-on-one interviews of people with recently diagnosed knee
OA or undiagnosed symptoms consistent with knee OA.6 This was followed by a
consensus of rheumatology experts, then item reduction and internal consistency
evaluation.15 Velozo et al. also recommended using Rasch analysis to determine whether a
measure captures a unidimensional construct.16 However, this last recommendation has not
yet been conducted for the QuIKS and therefore is the main purpose of this paper.
In Rasch analysis, observed data are expected to fit the probabilistic relationship within and
between person estimates and item estimates as specified in the Rasch measurement
model.17 Consequently, a questionnaire with data that fits the Rasch model has a
unidimensional construct, thereby having interval-level measurement properties as
recommended for questionnaire measures.16, 18, 19 The current study sought to evaluate the
factor structure, the items’ category response structure, item- and person-fit, differential
item functioning, local item dependence, overall fit, unidimensionality, and the test
precision of the QuIKS using Rasch analysis. The secondary purpose was to subsequently
evaluate the known-groups validity and the convergent validity of the Rasch-refined
QuIKS.
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3.3
3.3.1

Methods
Design

This study used cross-sectional data. We recruited subjects into three distinct groups along
the following knee health continuum: pain-free healthy knees (HK), knee pain with no knee
OA diagnosis (KP), and surgeon-diagnosed knee OA scheduled for high tibial osteotomy
(pre-HTO). Subjects in the HK group self-reported no knee pain in the past three years and
were between the ages of 20-40 years. Subjects in the KP group had verbally complained
of knee pain lasting two or more weeks to their family physician within the previous three
years as recorded in their medical chart and were between the ages of 40-65 years. Subjects
in the pre-HTO group were between the ages of 40-65 years. The prevalence of knee OA
increases with age. Therefore, the HK group was younger than the two involved groups and
less likely to have knee OA. The HK group was recruited (March 2011 to January 2012)
from a university community through posted paper notices. The KP group was
retrospectively collected from data collected (April to August 2009) through a universityaffiliated medical clinic using mailed questionnaires as previously described.15 The preHTO group was prospectively collected (March 2011 to January 2012) through a
university-affiliated sports medicine clinic using mailed questionnaires. Each subject had to
be fluent in English to participate in this study. We excluded persons with gout, rheumatoid
arthritis, chronic low back pain, foot or hip pain, major co-morbidities, previous knee
arthroplasty, or high tibial osteotomy. These exclusion criteria helped to ensure that the
knee pain and the illness experiences of the subjects were consistent with symptomatic
knee OA. Ethics approval was granted by Western University’s Health Sciences Research
Ethics Board, see Appendix B. Each participant provided written informed consent.

3.3.2

Participants

The total sample was 200 subjects along the knee health continuum. The HK, KP, and preHTO group had 55, 111, and 34 subjects, respectively.
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3.3.3

Outcome measures

The sample descriptive data included sex, age, body mass index (BMI), affected knee
(unilateral, bilateral, or none), family history of arthritis (yes or no), and history of knee
injury (yes or no). To indicate the structural severity of knee OA, a single rater recorded the
Kellgren and Lawrence grade from standard weight-bearing radiographs of each
symptomatic knee in the pre-HTO group.20 A Kellgren and Lawrence grade of 0, 1, 2, 3,
and 4, represented normal, doubtful, minimal, moderate, and severe knee (tibiofemoral)
OA, respectively.20

3.3.3.1

The QuIKS

We analysed the QuIKS, but data were collected on its 35-item prototype questionnaire ( as
in the initial validation of the questionnaire) to allow for consistency of data collection
across the study groups.15 The QuIKS has 13 items and four subscales, and each item has a
5-point rating scale. Each of its four subscales captures one or more components of illness
perception and behaviour. Some items use an adjectival scale to quantify frequency (0 =
never, 4 = always), while others use Likert responses ranging from strongly disagree (0) to
strongly agree (4). The 3-item medication subscale captures medication usage to relieve
knee pain, reflecting self-care and professional-guided care. The 3-item monitoring
subscale captures a person’s awareness of their knee symptoms, reflecting illness
recognition and evaluation.21 The 4-item interpreting subscale captures one’s understanding
of one’s symptoms, reflecting information and health-care seeking, and illness recognition
and labeling.21 The 3-item modifying subscale captures an individual’s changes or intention
to change engagement in activity in order to avoid progressive knee damage, reflecting the
principles of selection of, optimization of, and compensation for activity engagement.22, 23
However, since each subscale may be the operationalization of one or more components of
illness perception and behaviour, combining these subscales into a single measure might
reflect a higher-order construct of illness perception and behaviour. This higher-order
construct would be expected to be unidimensional. When normalized, the summative total
score of the subscales of the QuIKS varies from 0-100 (worst to best state).
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3.3.3.2

The KOOS

The KOOS is a 42-item knee-specific self-administered questionnaire.24 It captures health
status in the following five subscales: pain, other symptoms, activities of daily living, sport
and recreation function, and knee-related quality of life.24 The total score of each subscale
was normalized to a 0-100 scale (extreme to no problems). The KOOS has been widely
used and has demonstrated validity, reliability and responsiveness for adults of all ages
with acute and chronic knee pain problems; i.e. knee injury and osteoarthritis.25, 26 The
KOOS was chosen to demonstrate the convergent validity of the QuIKS because both
measures have a similar target population. However, the KOOS evaluates symptoms
severity, function, activity, and quality of life, whereas the QuIKS evaluates the illness
perception and behaviour related to one’s knee pain symptoms.

3.3.4
3.3.4.1

Data analysis
Sample characteristics

Descriptive characteristics were summarized for the knee health groups. The Shapiro-Wilk
test evaluated the normality of the data within each group of knee health. Factor analysis
and Rasch analysis used only the KP and pre-HTO groups combined (n = 145), because
scores within the HK group were extreme and would not contribute to these analyses. Most
data analyses were performed with SPSS version 20.0 (SPSS Inc, Chicago, Illinois).

3.3.4.2

Factor analysis

As recommended by Tennant and Pallant (2006),27 Horn’s parallel analysis was performed
to determine the number of factors to extract from the QuIKS prior to its Rasch analysis.27,
28

This determined whether the QuIKS had only a single dominant construct as required for

proceeding to Rasch analysis.27 Horn’s parallel analysis uses principal components
analysis (PCA) with Monte Carlo simulation to determine the number of factors in a
dataset. It identifies the number of factors with an empirical eigenvalue greater than the
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corresponding eigenvalue generated from 1000 random datasets at a 95% confidence
level.28 Horn’s parallel analysis is more accurate than other forms of factor analysis, such
as the eigenvalues-greater-than-one rule and the scree plot.28 Following parallel analysis,
PCA with varimax rotation determined the percentage variance explained by each factor.

3.3.4.3

Rasch analysis

A Rasch analysis approach was used to evaluate the fit of the data collected by the QuIKS
to the Rasch mathematical model.29, 30 The RUMM2030 software (RUMM Laboratories,
Perth, Australia) was used, which is a sophisticated and widely used software that is
specialized for Rasch analysis. An estimated minimum sample size of 144 subjects was
adequate for Rasch analysis for items calibration with ± 0.05 logits at 95% confidence even
if the scale is poorly targeted.31 However a minimum sample size of 100 subjects is
considered to be adequate in most cases at this confidence level.31
We hypothesized that the QuIKS would contain a unidimensional dominant construct,
conceptualized as illness perception and behaviour that represented the key experiences
consistent with symptomatic knee OA. We used the following 12 steps and previously
published fit criteria for the Rasch model to investigate this hypothesis.30
Step 1: to evaluate goodness-of-fit, the data were divided into two class intervals using the
subjects’ total scores. Step 2: a Fishers Likelihood test was performed. If significant (P
<0.05 with Bonferroni correction for the number of items), it would suggest that the partial
credit model version of the Rasch model should be used.32 Step 3: data for misfitted
subjects, those with residual values outside ±2.5, were removed to allow for an accurate
estimation of the questionnaire’s measurement properties. Step 4: response categories of
the individual items were expected to be sequentially ordered. Disorder occurred when any
response category for an item always had less than 50% probability of being endorsed
when compared to each adjacent response category. When disordered response categories
were identified, the response structure of the rating scale was corrected by combining two
or more adjacent response categories. Step 5: the fit of each item was evaluated. Items
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misfitted the model if their residual value was above +2.5 and/or had a significant chisquare (χ2, P < 0.05 with Bonferroni correction for the number of items in the
questionnaire). Any misfitted item was deleted because it did not align with the construct
captured collectively by the other items. All the preceding steps were iterative.
Step 6: the remaining data were evaluated for summary fit with the Rasch model as defined
by a non-significant item-trait interactive χ2 (P < 0.05 with Bonferroni correction), mean
person- and mean item- residual value (standard deviation) of ~0 (~1). Step 7: each item
was examined for differential item functioning (DIF) across two subject characteristics
considered clinically relevant to the experience of illness perception and behaviour: sex
(male/female) and body mass index (i.e., BMI cut point obese [≥30 kg/m2]/not obese) using
two separate two-way analysis of variance (ANOVA) procedures. In each two-way
ANOVA, the two independent variables were the subjects’ overall construct estimate
divided into two class intervals and a subject characteristic. Each item had one mean score
for the subjects in each class interval which formed the dependent variable. An item with
DIF does not provide consistent estimation of the construct across the categories of the
subject characteristics for subjects with equal overall estimates.30 Step 8: item pairs with
their residual correlation > 0.2 after mathematically removing the dominant construct, were
considered to have displayed local item dependency, which means that those items were
associated beyond the dominant construct in the questionnaire.33 Such items were
combined into a testlet.33
A testlet is a group of two or more very closely associated items that give a similar estimate
of a subject’s level of the construct. Testlets are sub-constructs of a scale, whereas
subscales may or may not be sub-constructs. Step 9: the misfitting subjects’ data (from
step 3) were re-entered and the changes to the QuIKS in step 1 to 6 were repeated. This
allowed all subjects who fit the Rasch-refined QuIKS to be accounted for in the subsequent
steps of Rasch analysis. Step 10: we formally evaluated whether the dominant construct
was unidimensional.
Unidimensionality is a vital component for interval-level measurement. In the context of
testlets, the construct was the common variance (A) among the testlets.33, 34 Each subject
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had an estimate generated for two exclusive sets of items, using the Smith method.35 The
two estimates for each subject were then compared using an independent t-test.35
Unidimensionality was confirmed if less than 5% of subjects had significant t-scores, as
estimated by the lower bound of a binomial 95% confidence interval.30 Step11: reliability
(or scale precision) was then evaluated using the Person Separation Index (PSI). A PSI
value of 0.8 indicated the questionnaire can distinguish subjects in up to three levels of the
dominant construct, which is the minimum acceptable level for a measurement scale.36 Step
12: targeting of the sample by the refined QuIKS was evaluated. This step investigated
whether the spectrum of the construct captured by the refined QuIKS covered the spread of
the construct in the sample. Ideally, the difficulty thresholds of the items should be
adequately spread to capture the quantity of construct in every subject. Statistically, this
was indicated by a mean person estimate (standard deviation) of ~1 (~0) when the mean
item estimate was zero on the same logit (log-odd units) scale of the dominant construct.
Also in this step, the estimate of each testlet was determined. This allowed us to determine
the hierarchical order of the testlets on the dominant construct based on their logit scores.
Lower logit scores represented the tendency of an item or testlet to capture lower levels of
the dominant construct. A floor effect and ceiling effect were 15% or more subjects with
the maximum or minimum scores, respectively.37 If the QuIKS was adequately validated
by Rasch analysis, we adapted a conversion formula,38 and transformed its summative total
raw scores to interval-level scores.

3.3.4.4

Confirmatory factory analysis

This was performed to test the factor structure in the Rasch-refined QuIKS. Version 7.3 of
the Mplus software (Muthén & Muthén, Los Angeles, California) was used.39 Model fit
was evaluated using the following fit indices and cut-off criteria for adequate fit;
comparative fit index (CFI, >0.90), the Tucker-Lewis index (TLI, >0.90), and the rootmean-square error of approximation (RMSEA, <0.08).40
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3.3.4.5

Known-groups analysis

We hypothesized that the total scores from the Rasch-refined QuIKS would be significantly
higher for the HK versus the KP group (n = 166), and higher for the KP versus the preHTO group (n = 145) with at least a moderate effect size. The estimated sample size was
52 subjects per group for a moderate effect size.41 We used the Kruskal-Wallis H test (the
non-parametric version of a 1-way ANOVA) with the Mann-Whitney U test (the nonparametric version of an independent t-test) for post-hoc testing because the data had a
non-normal distribution. Effect size (r) from the Mann-Whitney test was calculated as r =
z/√n and then converted to Cohen’s d = 2r/√(1 - r2), where z was the z-score value obtained
from the Mann-Whitney test and n was the total sample used in the analysis.42 A Cohen’s d
of 0.41 was considered small and the minimum effect size for a clinically relevant effect,
1.15 and ≥2.70 were moderate and strong effects, respectively.43 The 95% confidence
interval (CI) of Cohen’s d was calculated as d ± 1.96*Standard Error.44

3.3.4.6

Convergent validity

We hypothesized that a moderate correlation would be observed between scores on the
Rasch-refined QuIKS and each subscale of the KOOS. This hypothesis was based on
reasoning that the KOOS subscales should be moderately related to a measure that
identifies responses to early symptoms of knee OA. Spearman correlation coefficients (rs)
quantified these relationships. The HK group was excluded to prevent errors in rs that
would be caused by their extreme scores. Moderate correlation of rs ≥ 0.5 supported
convergent validity.45 This analysis required an estimated sample size of 129 subjects,
calculated using an rs of 0.7 (95% CI = 0.5 to 0.9) at an alpha value of 0.05, which was
adequately met by the present study sample.46
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3.4
3.4.1

Results
Sample characteristics

Response rate was 63.0% for the KP and pre-HTO group, and not applicable to the HK
group.15 The sample characteristics are summarized in Table 3.1.

3.4.2

Number of factors

Table 3.2 shows the results of Horn’s parallel analysis. Only the first factor had an
empirical eigenvalue (5.97) that was greater than the corresponding randomly generated
eigenvalue (1.67). These results indicated a single factor solution for the QuIKS which
explained 45.9% of the total variance in its score.
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Table 3.1 Sample characteristics by study groups
Characteristics

Known Groups
Healthy
Knees,

Knee Pain,

Knee
Osteoarthritis
(pre-HTO),

Knee Pain and
pre-HTO,

n = 55

n = 111

n = 34

n = 145

24.7 (4.4)

52.1 (6.8)

48.9 (6.5)

51.3(6.8)

35 (63.6)

62 (55.4)*

9 (36.0)

71 (49.0)

22.9 (3.1)

28.1 (9.1)

29.1 (4.7)

28.3 (8.3)

Unilateral (%)

1(1.8)

61 (55.0)

18 (52.9)

79 (54.5)

Bilateral (%)

4 (7.3)

49 (44.1)

16 (47.1)

65 (44.8)

50 (90.0)

1 (0.9)

0

1 (0.7)

23 (42.6)*

52 (46.8)*

11 (33.3)*

63 (43.4)†

3 (5.5)

77 (69.4)‡

23 (71.9)†

100 (69.0)§

2 (3.6)

51 (45.9)

32 (100)†

83 (57.2)║

--

--

0/10/20/11/4

--

Other symptoms

100 (7.1)

53.6 (19.6)

37.5 (29.5)

53.6 (21.4)

Pain

100 (2.8)

80.6 (27.8)

48.6 (23.6)

72.2 (30.6)

Age, years
mean (SD)
Sex
Female (%)
BMI, kg/m2
mean (SD)
Affected knee

None (%)
Family history of arthritis
Yes (%)
History of knee injury
Yes (%)
History of knee pain
Yes (%)
Kellgren and Lawrence Grade,
Number of knees with
Grade 0/1/2/3/4
KOOS, range = 0-100 (worst to
best state), median (IQR)
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ADL

100 (0)

89.7 (23.2)

58.8 (27.7)

80.9 (29.4)

Sport & Recreation

100 (0)

75.0 (40.0)

17.5 (39.1)

58.0 (50.0)

QOL

100 (0)

68.8 (31.3)

15.6 (31.3)

56.3 (43.8)

Missing data * n=1, † n=3, ‡ n=4, § n=9, ║n=2.
BMI, Body mass index
KOOS, Knee injury and Osteoarthritis Outcome Score
ADL, Activities of Daily Living
QOL, Quality of Life
IQR, Inter-quartile range
Kellgren and Lawrence grade severity: 0 (normal) is no OA; 1 (doubtful) is possible joint space narrowing
and osteophytes, 2 (minimal) is definite joint space narrowing and osteophyte, 3 (moderate) is definite joint
space narrowing, multiple osteophytes, some sclerosis and possible bone contour deformity, 4 (severe) is
marked joint space narrowing, large osteophytes, severe sclerosis and definite bone contour deformity.20
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Table 3.2 Results from factor analysis using Horn’s parallel analysis

Factor

Empirical Eigenvalue
(95% CI)

Randomly Generated

Percent Variance

Eigenvalue

Explained based on
empirically generated
eigenvalue

*

1*

5.97 (5.02, 6.92)

1.67

45.9

2

1.35 (1.13, 1.57)

1.49

10.4

3

1.22 (1.03, 1.41)

1.36

9.3

4

1.12 (0.94, 1.30)

1.26

8.6

5

0.69 (0.58, 0.80)

1.18

5.2

Only factor suitable for extraction from the QuIKS.
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3.4.3

Data fit to the Rasch model

Rasch analysis used the partial credit model. The main results of the Rasch analysis are
summarized in Table 3.3. Initially, the QuIKS did not fit the Rasch model. Therefore, its
measurement properties were refined through eight rounds of Rasch analysis. One set of
modifications or data manipulation was performed in each round of Rasch analysis, guided
by information obtained in the preceding rounds.
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Table 3.3 Summary fit statistics from Rasch analysis

Version

Data changes

Sample
size

Item-trait interaction χ2

Item fit residual

Person fit residual

Significant
PSI

Value (df)

P value

Mean

SD

Mean

SD

t-tests, %

Initial

None

145

73.512 (13)*

0.000

0.49

1.84

-0.22

1.18

0.89

7.0

Run 2

Deleted 8 misfit
persons

137

72.550 (13)

0.000

0.43

1.93

-0.14

1.01

0.90

5.2

Run 3

Rescored all items

137

19.693 (13)

0.103

-1.01

1.21

-0.66

1.29

0.89

1.6

Run 4 †

Deleted 20 misfit
persons

117

16.105 (13)

0.243

-0.58

1.12

-0.41

1.08

0.90

4.8

Run 5

Formed 4 testlets

117

0.937 (4)

0.92

0.26

0.72

-0.35

0.87

0.84

1.3

Run 6 †

Used initial data,
rescored all items

145

19.480 (13)

0.108

-1.07

1.33

-0.70

1.33

0.89

4.3

Run 7

Formed the 4 testlets
again

145

3.546 (4)

0.47

0.02

0.85

-0.45

0.89

0.83

2.9

Run 8

Deleted 1 misfit
persons

144

3.612 (4)

0.46

0.03

0.85

-0.43

0.86

0.82

2.9

RaschRefined

Deleted 3 persons
with incomplete data

141

3.613 (4)

0.46

0.00

0.87

-0.44

0.86

0.82

3.0

*

Significant after P < 0.05 with Bonferroni correction for the number of items in the analysis. † Had local item dependency. Criteria of fit to Rasch

Model: minimum sample size of n = 108, PSI (Person Separation Index) ≥ 0.80 for reliability assessment by measurement scale, P-value of χ2 >
0.05[Bonferroni-adjusted], Items- and Persons- Fit Residual Mean ~ 0 and SD (Standard Deviation) ~ 1, less than 5% significant t-test.
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Eight items had disordered thresholds. There was equitable utilization of response
categories across most items. The exceptions were items of the medications subscale, for
which the subjects predominantly endorsed the ‘None – 0’ category. Rescoring the
category response structure of all 13 items from five-level to three-level numeric response
categories resolved all threshold disorders. In this new category response structure, the
middle three response options have the same value (e.g. 0-1-2-3-4 became 0-1-1-1-2), thus
assigning an equal score for the three inner response categories. As an example, figure 3.1
depicts the category probability curves of one item of the modifying subscale before and
after being rescored. There was no DIF.
The residual correlation matrix of the items indicated that the four subscales had local item
dependency, which grouped the items into their respective subscales. Only one pair of
items of the interpreting subscale had residual correlations >0.2, but its items were still
considered a subscale because their residuals were most correlated with each other. The
results from Horn’s parallel analysis, coupled with these results, suggested that the
dominant construct in the QuIKS is a higher-order factor, while its subscales are lowerorder factors. Existing theory, prior research and the preceding results in this study guided
our decision to form four testlets corresponding to the original four subscales. There was a
large proportion of common variance (A = 0.93) among the testlets, which indicated that a
single dominant construct (i.e., illness perception and behaviour) was captured by the
QuIKS. Finally, data for four subjects were removed; one subject with an individual data
pattern that misfitted the Rasch model and three subjects who each had data missing for
one item.
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Panel A: Before Rescored

Panel B: After Rescored

Figure 3.1 Category probability curves of one item from the modifying subscale - ‘I
participate in certain activities less often to avoid aggravating my knees’ before formation
of testlets. Panel A depicts disordered response category thresholds. Panel B depicts the
item’s response scale after the three inner response categories were rescored to have an
equal value of one, thus creating a logical and sequential ordering of its thresholds.
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This refined QuIKS conformed to the expectations of summary fit to the Rasch model, as
revealed by a non-significant item-trait interaction χ2, see Table 3.3. Only 3.0% of subjects
had significant independent t-tests, confirming the unidimensionality of the illness
perception and behaviour construct in the refined QuIKS. This Rasch-refined QuIKS had a
PSI of 0.82, which is adequate to distinguish up to three distinct levels of illness perception
and behaviour. Figure 3.2 depicts findings that suggested the Rasch-refined QuIKS was
suitable for assessing the subjects, because the mean (SD) person estimate was 0.08 (1.19)
with an item estimate mean of 0.00. The subscales of the Rasch-refined QuIKS had a
hierarchical order from less to more illness perception and behaviour in logit scores as
follows: monitoring (-0.886), modifying (-0.192), interpreting (-0.112) and medication
(1.19). There were no floor or ceiling effects. The Appendix provides the Rasch-refined
QuIKS. A table at the bottom of the Rasch-refined QuIKS (see Appendix A) provides the
interval level scores (vary 0 to 100) that correspond to the total raw scores (vary 0 to 26).
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Figure 3.2 Fitting persons and items threshold distribution on the same logit scale.
The distribution of the subjects’ estimate of illness perception and behaviour is in the upper
histogram, with increasing illness perception and behaviour from left to right on the x-axis.
The distribution of the 13 items threshold estimate is the lower histogram, with higher
illness perception and behaviour from left to right on the x-axis.
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3.4.4

Factor structure of QuIKS

Results from confirmatory factor analysis substantiated the results from the Horn’s parallel
analysis and Rasch analysis. We tested the one-dominant construct (second-order factor)
and four-testlet (first order factors) structure of the 13-item Rasch-refined QuIKS, and the
data showed adequate fit to the model [CFI = 0.94, TLI = 0.92, and RMSEA = 0.08 (95%
CI = 0.06-0.10]. Thus, the Rasch-refined QuIKS conformed to a unidimensional model.

3.4.5

Known-groups validity

The Kruskal-Wallis H test, where H is the test statistic, revealed that the total scores on the
Rasch-refined QuIKS were significantly different among the three knee-health groups (H =
123.01, df = 2, and P < 0.001), with a median (inter-quartile range) of 100.0 (12.7) for HK,
52.9 (21.4) for KP, and 29.7 (13.8) for pre-HTO. There was a statistically significant
moderate effect size between the HK and KP groups (n = 166) with Cohen’s d = 2.20 (95%
CI = 1.81-2.60), z = -9.615, and P < 0.001, which indicated less illness perception and
behaviour in the HK group compared to the KP group. There was a significant moderate
effect size between the KP and pre-HTO groups (n =145) with Cohen’s d =1.32 (95% CI =
0.99-1.66), z = -6.641, and P < 0.001.

3.4.6

Convergent validity

The QuIKS had a statistically significant moderate correlation (rs = 0.45-0.77) with each
KOOS subscale. Its lowest correlation was with the KOOS-other symptoms (rs = 0.45),
followed by the KOOS-sports and recreation function (rs = 0.65), the KOOS-activities of
daily living (rs = 0.70), the KOOS-Pain (rs = 0.72), and its highest correlation was with the
KOOS-quality of life (rs = 0.77).
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3.5

Discussion

Our findings affirmed all the hypotheses in this study. An updated version of the QuIKS,
called the QuIKS-R, was adequately validated using information from Rasch analysis. The
results suggest that the QuIKS-R encapsulates all four of its subscales into a
unidimensional measure of illness perception and behaviour that captures the key
experiences of knee pain symptoms that are consistent with knee OA. For clinicians and
researchers, these findings mean that ratings on the QuIKS-R can be validly summed,
much like marks on a ruler. First, calculate the total raw score, then use the conversion
table at the bottom of the QuIKS-R (see Appendix A) to obtain the corresponding intervallevel (final) total score. These interval-level scores represent an individual’s level of
illness perception and behaviour. To the best of our knowledge, the QuIKS-R would be the
first unidimensional measure designed to quantify illness perception and behaviour
specifically for people with early symptoms of symptomatic knee OA.10, 11
It made conceptual sense to condense the three middle response categories of each item,
given the descriptors used for these categories. In the medication subscale we combined
‘Rarely’, ‘Sometimes’, and ‘Often’. We did this because it might have been difficult for
subjects to recall their illness response and then choose a response category that best
classified their experience. It is possible that the subjects did not use a consistent pattern
when selecting between ‘Rarely’ and ‘Sometimes’ and between ‘Sometimes’ and ‘Often’.
Perhaps more clearly defined descriptors, for example, ‘Rarely = 1 to 3 times per week’,
‘Sometimes = 4 to 6 times per week’, and ‘Often = 7 to 9 times per week’ would remove
ambiguity from among these categories.47 Furthermore, the other 10 items used five-point
Likert scales with a ‘Neutral’ midpoint. The rescoring of these items could be explained in
the context of the long history of debate on the implication of midpoints in rating scales.48
A midpoint, such as ‘Neutral’, is sometimes misinterpreted or selected in a biased way.48
However, its removal might push some respondents to choose adjacent categories,
reducing the reliability and validity of the measure.48 Therefore, scoring the midpoint in the
same manner as its adjacent categories was deemed a good solution for these two issues.
This study suggests that the level of illness perception and behaviour increased as
individuals moved from the monitoring, to the modifying, then the interpreting, and finally
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to the medication subscale. This pattern means that subjects tended to indicate higher
ratings on the monitoring subscale compared to the medication subscale. This pattern fits
with the model of illness behaviour, the latter being a representation of the decision-making
process during an illness.21 This model employs nine stages, starting from illness
recognition and labeling to the application of treatment with consequential re-evaluation of
the illness state by the individual, in an iterative process.21 Furthermore, the model of
selective optimization with compensation 23 also offers a theoretical basis for some of the
items in the QuIKS-R, as it provides an explanation of the process of adaptation in people
with knee pain problems. For example, in the early stages of symptomatic knee OA, one
would expect that a person might make the decision to stop engaging in a favorite activity
because of their knee pain (selection), change their exercise routine because of the knee
problem (compensation), and take medication before engaging in an activity to prevent
pain (optimization).23, 49 For clinicians these findings mean that scores on the QuIKS-R
capture on a continuum illness perception and behaviour of people with knee pain
symptoms that are consistent with knee OA.
Forming testlets to obtain unidimensionality demonstrated that the subscales of the QuIKS
are sub-constructs of illness perception and behaviour. When measuring a construct,
measures with fewer items tend to have higher accuracy but lower precision.18, 19 By
forming the testlets, we were able to capitalize on the accuracy of the subscales while also
capitalizing on the precision of the full questionnaire, thereby providing more information
about an individual’s level of illness perception and behavior in a single score. It is worth
noting that the individual testlets should not be used for score interpretation. Only the total
scores from all 13 items of the QuIKS-R should be interpreted, and this interpretation
should be in the context of the higher-order construct of illness perception and behaviour.
The QuIKS-R discriminated between the study groups. The pre-HTO group had the highest
level of illness perception and behaviour, followed by the KP, then the HK group, with a
significant between-group difference of at least a moderate effect size. There are no
previous studies of the QuIKS with which to compare these findings. However, populationbased reference data of each subscale of the KOOS supports the values obtained in the
present study.50, 51 For example, the KOOS-pain median score for the KP and pre-HTO
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groups were 80.6 and 48.6 respectively, and 97.2 for people aged 35 to 54 years in a
population-based group.50 This is logical given that the prevalence of symptomatic knee
OA increases with age and OA-related knee pain usually becomes more severe over time.3,
52

A lower correlation between the QuIKS-R and the KOOS-other symptom subscale, when

compared to the QuIKS-R’s correlation with the other KOOS subscales, could mean that
the level of illness perception and behaviour in the study population was less related to
other joint impairments but highly related to activity limitations and knee-related quality of
life. For clinicians, these findings mean that the QuIKS-R may be useful in discouraging
physical activity limitations and helpful in promoting or maintaining quality of life in
patients with knee pain symptoms consistent with knee OA.
One of the main advantages of the QuIKS-R over the original 13-item QuIKS is the
unidimensionality it gained after the ambiguity was removed from the rating scale of each
item. This finding suggests that the QuIKS-R has an improved ability to discriminate
compared to its predecessor. Also, along with its validity specifically for people with OAlike knee pain, a main advantage of the QuIKS-R over other measures of illness perception
and behaviour is its proposed ‘unified construct of illness perception and behaviour’.

3.6

Limitations and future research

A limitation of this study was that the subjects in the KP group did not receive a medical
diagnosis, so their knee pathology could be unrelated to knee OA. Also, while knowngroup (discriminative) validation supported the QuIKS-R ability to discriminate the level
of illness perception and behaviour between the healthy group and two severely involved
groups, this information might not be useful for a clinician’s assessment of individual
patients. Future studies should use a larger sample and evaluate the predictive validity of
the QuIKS-R in identifying subjects with OA-like knee pain who are at greatest risk for
physical activity limitations.
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3.7

Conclusions

The QuIKS-R is a unidimensional measurement scale that provides an interval-level score
of illness perception and behaviour in persons with knee pain symptoms consistent with
symptomatic knee OA. Scores on the QuIKS-R that represent more illness perception and
behaviour, also mean that a patient is more aware of and affected by their knee pain, and
has tried more to remedy their condition. This information might be useful for clinicians in
guiding pain management interventions by identifying important issues to address in the
therapy of people experiencing early symptoms of symptomatic knee OA.
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Chapter 4

4

Behavioural measures in a rat model of post-traumatic
knee OA

This chapter was reprinted with permission. A version of this chapter has been published
as:
Hamilton CB, Pest MA, Pitelka V, Ratneswaran A, Beier F, Chesworth BM. Weightbearing asymmetry and vertical activity differences in a rat model of post-traumatic knee
osteoarthritis. Osteoarthritis and Cartilage. In press (2015).
doi:10.1016/j.joca.2015.03.001.

4.1 Abstract
Objective: This study used a rat model of post-traumatic knee OA created by anterior
cruciate ligament transection with partial medial meniscectomy (ACLT + pMMx). In this
model, mild to moderate structural changes that are typical of knee OA have been observed
within two and eight weeks post-surgery. The aim was to determine whether pain-related
behaviours can distinguish between an ACLT + pMMx and a sham surgery group.
Design: Three-month old male Sprague-Dawley rats underwent ACLT + pMMx on their
right hindlimb within two groups of n = 6 each, and sham surgery within two groups of n =
5 each. Assessments evaluated percent ipsilateral weight-bearing for static weight-bearing
and 18 different variables of exploratory motor behaviour at multiple time points between
one and eight weeks post-surgery. Histology was performed on the right hindlimbs at four
and eight weeks post-surgery.
Results: Histology confirmed mild to moderate knee OA changes in the ACLT + pMMx
group and the absence of knee OA changes in the sham group. Compared to the sham
group, the ACLT + pMMx group had significantly lower percent ipsilateral weight-bearing
from one through eight weeks post-surgery. Compared to the sham group, the ACLT +
pMMx group had significantly lower vertical activity (episode count, time, and count)
values.
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Conclusions: These findings suggest that ipsilateral weight-bearing deficit and vertical
activity limitations resulted from the presence of knee OA-like changes in this model.
When using the ACLT + pMMx-induced rat model of knee OA, percent ipsilateral weightbearing and vertical activity distinguished between rats with and without knee OA changes.
These variables may be useful outcome measures in preclinical research performed with
this experimental post-traumatic knee OA model.
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4.2

Introduction

The clinical presentation of knee OA typically involves chronic pain and physical
disability.1 Pain does not always accompany knee OA, but symptomatic knee OA is very
prevalent.2, 3 For example, the lifetime risk of developing symptomatic knee OA in the US
has been estimated to vary between 9.6% and 23.9%, depending on a person’s age, sex, and
obesity status.3 In humans, the presence of OA pain is associated with negative outcomes
such as activity limitations, participation restrictions, and reduced quality of life1. These
symptoms may be observed as behavioural changes, beginning at the early stages of the
disease before diagnosis, and continuing through to its late stages.4-6
Several rat models of OA serve as surrogates to the disease in humans, and are useful in
preclinical studies on pharmacology and pathophysiology of the disease.7 Chemical
(particularly, monosodium iodoacetate - MIA) and surgical induction methods are the two
most commonly used to create experimental knee OA models with rats.7, 8 The surgical
induction methods are particularly suited for studying post-traumatic knee OA.
In humans, previous ligamentous knee joint injury, such as an ACL tear, is a major risk
factor for knee OA.9 In most instances, an ACL tear is accompanied by a meniscal tear.10
On average, 50% of individuals develop knee OA within 10 to 20 years after an ACL
tear.10, 11
We used a preclinical rat model of post-traumatic knee OA created by ACL transection
with partial medial meniscectomy (ACLT + pMMx).12-15 The model acts by destabilizing
the joint and disrupting its biomechanics, and thus has high clinical relevance in the study
of knee OA.12 This model’s changes in joint structure and gene expression have been well
characterized in previous studies.12-15 Histology and micro-computed tomography (µCT) of
the knee joints have demonstrated the presence of changes that were characteristic of mild
to moderate knee OA in the ACLT + pMMx rats between two and eight weeks postsurgery.12 The structural changes have been determined to be similar to early stage knee
OA in humans.12 In rat models of post-traumatic knee OA, some aspects of their painrelated behaviours have been characterized, such as weight-bearing deficit and gait
changes.7 However, static weight-bearing and exploratory motor behaviour (spontaneous
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locomotor activities) have not been previously published for this particular model, to the
best of our knowledge.
The assessment of pain and physical function are vital components of the clinical
assessment of patients with symptomatic knee OA.16 The assessment of pain-related
behaviour is becoming more popular in rat models of OA because of its utility for
increasing the translatability of animal studies to human clinical settings.7, 17 This increased
popularity is made evident by the recent special issue from the journal Osteoarthritis and
Cartilage on ‘Pain in Osteoarthritis’ and other recent publications.7, 8, 17 The special issue
highlighted the use of pain-related behaviour assessments in rat models of knee OA.7, 8
Most of this published work has been done with MIA induced rat models of OA that induce
mechanical allodynia, which is common in painful non-injured sites in humans.8, 18
Exploratory motor behaviour, as investigated in the present study, has not been previously
published for any rat model of post-traumatic knee OA but has been used with other postsurgery rodent models.17 Exploratory motor behaviour was recently characterized for a
mouse model of post-traumatic knee OA by testing spontaneous locomotor activity in an
open field tester.19 The investigators found no difference between the model and sham
groups, which might be a consequence of the period of assessment or the variables of
exploratory motor behaviour that were studied.19 Other studies using rat models of knee
OA have observed certain characteristics of activity limitation such as reduced locomotion,
rearing and climbing.7, 20, 21 Pain-related behaviour exhibited by a rat model of OA is
dependent on the type rather than the extent of joint damage.7, 22
Therefore, the aim of this study was to determine whether static weight-bearing and
variables of exploratory motor behaviour in rats can be used to distinguish between an
ACLT + pMMx-induced rat model of post-traumatic knee OA and a sham surgery control.
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4.3
4.3.1

Methods
Animals

All experimental procedures were conducted in accordance with protocols approved by the
University of Western Ontario Animal Care and Use Committee in agreement with federal
regulations (Animal protocol No. 2007-045). Subjects were male Sprague-Dawley rats
(Charles River Laboratories, St. Constant, Quebec, Canada) that arrived at 10 weeks old
and weighed between 301g to 325g. The rats were caged doubly and then singly after
surgery in a ventilated animal room with controlled temperature (20 oC to 25 oC) and
controlled humidity (40% to 60%). They were placed on a 12 hour light/dark cycle starting
at 7 am and received food and water ad libitum.

4.3.2

Study design

Figure 4.1 is a schematic of the experiment protocol. Rats were randomly allocated to the
two main study groups, two alternate groups, and a naïve group (n = 5). The alternate
ACLT + pMMx and sham groups were sacrificed at four weeks post-surgery, and the main
study groups and the naïve group were sacrificed at eight weeks post-surgery by CO2
asphyxiation. Hindlimbs were harvested, then fixed in 4% paraformaldehyde overnight,
and decalcified for four days in Formical-2000 (Decal Chemical Corp.) for later
histological assessment. The alternate groups were treated in the same manner as the main
study groups, including behaviour assessments.

110

protocol. Three months old male Sprague–
Sprague
Figure 4.1:: Schematic of experimental protocol
Dawley rats were acclimatized for 1 week. They then underwent ACLT + pMMx (n = 6),
sham surgery (n = 5), or were naïve ((n = 5). At the same time, a drug delivery pump with
distilled water as vehicle was installed under the skin in the mid
mid-saggital
saggital region of the
back. Pump revision surgery was done at 4 weeks after induction surgery to install a newly
filled pump to replace the exhaus
exhausted pump. The rats were followed for 8 weeks after ACLT
+ pMMx or sham surgery, and static weight
weight-bearing
bearing and exploratory motor behaviour was
assessed at five and three post
post-surgery
surgery time points, respectively. Two alternate groups were
followed for 4 weeks post-surgery,
surgery, to access early knee structural changes.
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4.3.3

ACLT + pMMx-induced OA

The ACLT + pMMx group (n = 6) had surgery to their right hindlimb to induce the model
of post-traumatic knee OA using a well-established protocol previously described, without
forced mobilization following surgery.12-15, 23 The sham group (n = 5) had surgery only to
visualize the ACL and medial meniscus of the right hindlimb. Additionally, to emulate the
experimental conditions of pre-clinical drug treatment trials, an osmotic minipump (Alzet
2ML4) filled with sterile distilled water was surgically installed subcutaneously between
the scapulae of each rat in both the ACLT + pMMx and sham groups.24 A similar surgery
was performed four weeks later, to replace the now exhausted pumps with fresh
units. During surgery all rats were anaesthetized via isoflurane inhalation. Analgesic
buprenorphine (50µg/kg) was injected subcutaneously. This was done once pre-emptively
during the surgery and once every 8 hours up to 48 hours following the surgery.

4.3.4

Structural joint changes

Animals from the main ACLT+pMMx group and sham group were sacrificed eight weeks
post-surgery for histology assessments. The alternate groups were followed for four weeks
post-surgery before their knee joints were harvested for histology to confirm the presence
of early OA-related structural changes. Harvested limbs were processed and embedded in
paraffin wax following fixation and decalcification. Serial frontal sections were cut
spanning the loading portion of the ipsilateral (right) knee joint. Sections were stained from
six different depths spanning approximately 1200µm of the joint, using 0.04% toludine
blue.25 Structural joint changes were assessed by using the Osteoarthritis Research Society
International (OARSI) guidelines for histomorphometry and pathology scoring by a
blinded scorer (M.A.P.).26 This guideline is an ordinal grading system in which lower
scores represent less cartilage degeneration.26 Grading was performed for three zones for
each of medial tibial plateau (MTP) and the medial femoral condyle (MFC). For each, the
grades have numeric values of 0, 1, 2, 3, 4, and 5 with the corresponding descriptors being
none, minimal (5-10%), mild (11-25%), moderate (26-50%), marked (51-75%), and severe
(more than 75%) respectively. The final cartilage degeneration score for the MTP and for
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the MFC was calculated by summing the scores from the three zones of each respective
anatomic site.26

4.3.5

Static weight-bearing

Static weight-bearing was a construct of weight-bearing deficit between the ipsilateral
(right) and contralateral hindlimbs when a rat was stationary.7, 22 This was assessed during
the 12 hour light phase at one, two, four, six, and eight weeks post-surgery using an
Incapacitance Tester (Linton Instrumentation, Norfolk, UK) shown in Figure 4.2, with the
exception of the six weeks’ time point for the naïve group. During the assessment
procedure, each rat was habituated to a relatively static position in a conventional restrainer
and separate transducers recorded the average weight on each hindlimb over five seconds
for five trials. Changes in the hind paw weight-bearing distribution between the left
(contralateral control) and right (ipsilateral) hindlimbs were utilized as an index of joint
pain-like symptoms in the knees that had surgery to induce the model of knee OA.
Therefore, as a likely indicator of OA pain, percent ipsilateral weight-bearing was
subsequently calculated as weight on the ipsilateral hindlimb divided by weight on both
hindlimbs multiplied by 100 as per.27 The average percent ipsilateral weight-bearing per rat
at each time point was used in the statistical analyses.
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Figure 4.2: Incapacitance Tester. This instrument was used to assess static weightbearing.
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4.3.6

General exploratory motor behaviour

Exploratory motor behaviour is a common construct that has been used in numerous
pharmacologic and non-pharmacologic studies including small animal research dating back
to the 1950s.28, 29 It captures spontaneous locomotor activity within a given space and is
related to self-motivation and curiosity.7, 17, 28 Exploratory motor behaviour was assessed
during the dark phase in an unlit animal room using an open field tester (AccuScan
Instruments, Omnitech Electronic, Columbus, OH) with a transparent Plexiglas cage
(height = 33cm, width = 42cm, and length = 42cm), see Figure 4.3. The cage had three
pairs of sensors. Each pair of sensors had 16 infrared light beams, equally spaced, that
detected activity when broken. Two pairs of sensors captured activity in the horizontal
plane at the base of the cage, and one pair captured vertical activity at 19 cm above the
base of the cage. Data were automatically uploaded into a computer using the
accompanying software. During the assessment, the computer screen was covered to
minimize exposing the rats to illumination. Exploratory motor behaviour assessment was
started at four weeks post-surgery, after allowing sufficient time for early stage knee OAlike structural joint changes to begin and post-surgery pain to dissipate. Each rat explored
the open field for 30 minutes at four, six and eight weeks post-surgery. However, this
assessment was done only at eight weeks post-surgery for the naïve group. Eighteen
different variables of exploratory motor behaviour were captured, encompassing frequency
counts and duration of horizontal, sedentary, stereotypic, revolution movement and vertical
activities (see Table 4.1 for complete list). Disturbance of the rats was avoided during the
assessments to avoid influencing their movement.
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Figure 4.3: Open-field
field Tester. This instrument was used to assess exploratory motor
behaviour.
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Table 4.1: Repeated Measures ANOVA results for variables of exploratory motor
behaviour
Main Effects
Variable*

Interaction Effect

Group

Time

F(1,8), P-Value

F(2, 16), P-Value

Ambulatory Activity Count

3.61, 0.09

2.06, 0.16

0.160, 0.85

Ambulatory Activity Time

5.13x10-3, 0.99

4.93, 0.02

0.300, 0.74

Ambulatory Episode Count

0.040, 0.85

12.1, <0.001

7.31, 0.006

Horizontal Activity Count

3.55, 0.10

1.99, 0.17

0.135, 0.103

Locomotor Clockwise Revolutions

1.67, 0.219

3.58, 0.05

3.38, 0.05

0.300, 0.60

6.45, 0.01

7.72, 0.004

Movement Episode Count

0.389, 0.55

0.937, 0.41

0.767, 0.48

Movement Time

2.66, 0.14

0.731, 0.50

0.102, 0.90

Rest Episode Count

0.419, 0.54

0.922, 0.42

0.713, 0.51

Rest Time

2.67, 0.14

0.725, 0.50

0.103, 0.90

Total Distance

0.336, 0.578

6.07,0.01

0.740, 0.49

Stereotypic Activity Count

0.021, 0.89

2.06, 0.16

0.231, 0.80

Stereotypic Episode Count

0.027, 0.87

1.81, 0.20

0.227, 0.80

Stereotypic Episode Activity Count

2.99, 0.12

1.18, 0.20

0.037, 0.96

Stereotypy Time

0.457, 0.52

4.48, 0.03

0.014, 0.99

Vertical Activity Count

14.2, 0.005

3.29, 0.06

0.445, 0.65

Vertical Activity Time

16.4, 0.004

10.1, 0.002

0.874, 0.44

Locomotor Counter-Clockwise
Revolutions
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Vertical Activity Episode Count
*

16.7, 0.004

7.53, 0.005

0.383, 0.69

Distance is in centimeters, time is in seconds, count and revolution are in numbers.

Bolded P-values are significant at P < 0.05.
Only the three vertical activity groups showed a statistically significant main effect between the rat groups,
while seven variables had a statistically significant main effect by time, of which two had a significant
interaction effect.

118

4.3.7

Statistical analysis

Statistical analyses were conducted using the Statistical Package for the Social Sciences
v.20 (SPSS Inc. Chicago, Illinois) and GraphPad Prism® v4 (San Diego, California).
Graphs were constructed in GraphPad Prism® using means and their corresponding 95%
confidence intervals (CI).
Each dependent variable was a continuous variable, and had independence of observation
at each time point in this study. The following tests of the underlying assumptions of the
statistical analyses were performed and the data properties confirmed, unless otherwise
stated below. Any outliers in the data, for each dependent variable within each group, were
identified using the outlier labeling rule with the k coefficient = 2.2.30 Normality of the data
distribution was assessed using the Shapiro-Wilk test of normality. Homogeneity of
variance was assessed using Levene’s test for homogeneity of variance during the analysis
of variance (ANOVA) and Student’s unpaired t-test. Sphericity was assessed using
Mauchly’s test of sphericity during two-way repeated measures ANOVA. Differences
between groups were based on statistical significance. In all analyses, statistical
significance was tested with a two-tailed P < 0.05 with adjustment for multiple
comparisons where applicable, such as Tukey’s post hoc test after one-way ANOVA and
Bonferroni’s multiple comparison test that had one family with a family-wise alpha of 0.05
for each variable tested at each time point.

4.3.8

Analysis of static weight-bearing

We hypothesized that, from one through eight weeks post-surgery, percent ipsilateral
weight-bearing would have significantly lower values for the ACLT + pMMx group
compared to the sham group. This hypothesis was tested using two-way repeated measures
ANOVA, with post-surgery time point and rat group as the two independent variables, and
percent ipsilateral weight-bearing as the dependent variable. This was followed by
Student’s unpaired t-test of the main effects by rat group, one-way ANOVA with Tukey’s
post-hoc testing of main effects by post-surgery time, and univariate parsing of interaction
effects to evaluate static weight-bearing between and within the ACLT + pMMx and sham
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groups across the time points. If a significant difference was found between the rat groups
in the preceding analysis, Bonferroni’s multiple comparison test in GraphPad Prism® was
used to evaluate whether percent ipsilateral weight-bearing values in the ACLT + pMMx
and sham groups were significantly different from the values in the naïve group at four and
eight weeks post-surgery.

4.3.9

Analysis of exploratory motor behaviour

For each of the 18 exploratory motor behaviour variables, we hypothesized that at four and
eight weeks post-surgery, their values would have a statistically significant difference
between and within the ACLT + pMMx and sham groups. Each hypothesis was tested
using two-way repeated measures ANOVA as described for static weight-bearing. Each
exploratory motor behaviour variable was a dependent variable. If the values of a variable
were significantly different between the ACLT + pMMx and sham groups, Bonferroni’s
multiple comparison test in GraphPad Prism®, evaluated whether their values in the ACLT
+ pMMx and sham groups were significantly different from values in the naïve group at
eight weeks post-surgery.
Any dependent variable that had a significant difference between the ACLT + pMMx and
sham groups was subsequently evaluated for association with OARSI cartilage
degeneration scores at four and eight weeks post-surgery using Spearman’s correlation
coefficient (rs). Values range from 0 to ±1, with rs = -1 or 1 representing stronger
correlations.

4.4
4.4.1

Results
Animal characteristics

At surgery, the rats were about three months old with a mean (95% CI) weight of 409 (393426)g, 401 (386-415)g, and 390 (371-409)g for the ACLT + pMMx, sham, and naïve
groups respectively. There was no significant difference between the rat groups at surgery,
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or at four weeks and eight weeks post-surgery. Data of one rat from the ACLT + pMMx
group was removed due to significant upper outlier values on the three vertical activity
variables. Therefore, each group had 5 rats. Data from each dependent variable were
approximately normally distributed at each time point.

4.4.2

Structural changes of the joint

Evidence of cartilage degeneration (red arrowheads, [Figure 4.4(A)]) and osteophyte
development (yellow asterisks, [Figure 4.4(A)]) that were indicative of knee OA-like
changes, was found in the medial compartment of ipsilateral knee joints of the ACLT +
pMMx animals but not in the sham animals at four and eight weeks post-surgery. The
OARSI scores of cartilage degeneration showed a significant difference (P < 0.005, MannWhitney test) between the ACLT + pMMx and sham groups in both the medial tibial
plateau (MTP) and medial femoral condyle (MFC). These groups’ respective mean scores
of MTP degeneration at four weeks post-surgery were 4.2 (2.9-5.5) and 0.07 (-0.12-0.25)
and at eight weeks post-surgery were 6.0 (3.8-8.2) and 0.27 (0.15-0.38). These groups’
respective mean scores of MFC degeneration at four weeks post-surgery were 3.4 (2.3-4.5)
and 0.10 (-0.09- 0.29) and at eight weeks post-surgery were 5.8 (3.1-8.6) and 0.07 (-0.050.18) [Figure 4.4(B) and Figure 4.4(C)]. Minor cartilage degeneration was observed in the
lateral compartments of the ACLT + pMMx operated animals with significant differences
compared to the sham animals [Supplementary data, Figure 4.5 (A, B)]. Evidence of minor
fibrosis was identified in the medial but not the lateral synovium of the ACLT + pMMx
animals [Supplementary data, Figure 4.5(C)].
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Figure 4.4: Evidence of OA in ACLT + pMMx operated rats as shown by histology
(A) Representative toluidine blue stained sections of knee joints demonstrates histological changes congruent with early to mid OA in
ACLT + pMMx (n = 6) but not sham operated animals (n = 5). Cartilage degeneration (red arrowheads) and osteophyte development
(yellow asterisks) are indicated. (B) At 4 and (C) 8 weeks post-surgery, ACLT + pMMx rats showed significantly higher OARSI
cartilage degeneration scores in the MTP and MFC of operated knee joints. **P < 0.005, Mann–Whitney statistical test. The values are
presented as mean with 95% CI for each study group. T = medial tibia, F = medial femur.
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4.4.3

The ACLT + pMMx animals demonstrated less ipsilateral
static weight-bearing

Development of pain-like symptoms following ACLT + pMMx was supported by the static
weight-bearing analysis (Figure 4.5). The ACLT + pMMx group had significantly lower
percent ipsilateral weight-bearing when compared to the sham group. During the two-way
ANOVA, sphericity was assumed (Mauchly’s W = 0.257, P = 0.478), but the GreenhouseGeisser’s F values were used. Percent ipsilateral weight-bearing showed a significant
interaction effect between post-surgery time and rat group (F(2.95, 23.61) = 5.59, P =
0.005), and a significant main effect by rat group (F(1, 8) = 161.26, P < 0.001) and by time
(F(2.95, 23.61) = 13.1, P < 0.001). Student’s unpaired t-tests with normality and equal
variance assumed, showed that the ACLT + pMMx group had significantly lower percent
ipsilateral weight-bearing at each post-surgery time point when compared to the sham
control (Figure 4.5). One-way ANOVA with Tukey’s post-hoc testing showed that percent
ipsilateral weight-bearing in the ACLT + pMMx group was significantly lower for week
one compared to the other follow-up weeks (F(2.74, 10.96) = 7.60, P = 0.006), but not
among the other weeks (P > 0.05). Whereas, in the sham group, percent ipsilateral weightbearing was significantly higher at six weeks post-surgery compared to one week and four
weeks post-surgery (F(2.56, 10.24) = 10.7, P = 0.002). However, the percent ipsilateral
weight-bearing of the sham group was always equal to or greater than 50%.
Bonferroni’s multiple comparison test demonstrated that the mean percent ipsilateral
weight-bearing of the naïve group was not significantly different from the ACLT + pMMx
group at four weeks (t = 2.75, adjusted P = 0.103), but was significantly higher than the
ACLT + pMMx group at eight weeks post-surgery (t = 3.06, adjusted P = 0.020). Also, the
mean percent ipsilateral weight-bearing of the naïve group was not significantly different
from the sham group at both four weeks (t =0.658, adjusted P = 1.00) and eight weeks
post-surgery (t = 0.059, adjusted P = 1.00).
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Figure 4.5: Percent ipsilateral weight-bearing between rat groups. Percent ipsilateral
weight-bearing assessed static weight-bearing as a likely indicator of pain. Percent
ipsilateral weight-bearing was consistently statistically significantly lower for the
ACLT/pMMx rats when compared to the sham operated rats. *At each time point, the
groups had statistically significant difference at adjusted P < 0.001. The values are
presented as means with 95% CI for each study group at each assessed post-surgery time
point.
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4.4.4

ACLT+pMMx animals performed less rearing in exploratory
motor behaviour testing

Of the 18 variables of exploratory motor behaviour investigated, a significant difference
between the rat groups was only observed for the three variables that captured vertical (or
rearing) activity. Seven variables had a significant main effect by post-surgery time, and
two variables had a significant interaction effect (Table 4.1). For group effects, Student’s
unpaired t-tests showed that the ACLT + pMMx group had significantly lower vertical
activity (episode count, time in seconds, and count) values at each of the assessment time
points (Figure 4.4, Table 4.2). Only the sham group had a significant difference between
time points, as observed where stereotypic activity time was different between week six
and eight. Furthermore, for the sham group, six out of the other seven variables (the
exception being total distance) had a significant difference between four weeks and eight
weeks post-surgery (Table 4.2). Parsing of the two interaction effects revealed no
additional significant difference between the groups at each time point.
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Figure 4.6: Vertical episode count differed between rat groups. Vertical episode count
was one of eighteen variables used to assess dynamic pain-related behaviour. It is one of
the three vertical activity variable that consistently showed statistically significantly lower
values for the ACLT + pMMx rats when compared to the sham operated rats from 4
through 8 weeks post-surgery. *At each time point, the groups had statistically significant
difference at adjusted P < 0.05. The values are presented as means with 95% CI for each
study group at each assessed post-surgery time point.
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Table 4.2: Repeated Measures ANOVA post-hoc testing results for exploratory motor
behaviour
Post-surgery time, Sham and ACLT+pMMx group
Variable*

mean difference (95 % CI)
Week 4

Week 6

Week 8

Ambulatory Activity Count

1479 (-982 to 3940)

1177 (-1284 to 3639)

1732 (-729 to 4194)

Ambulatory Activity Time†

4 (-47 to 55)

-6 (-57 to 44)

3 (-48 to 53)

Ambulatory Episode Count†

-9 (-22 to 4)

0 (-14 to 13)

6 (-7 to 20)

Horizontal Activity Count

1462 (-1036 to 3961)

1190 (-1309 to 3689)

1718 (-780 to 4217)

3 (-20 to 25)

-12 (-35 to 11)

7 (-16 to 30)

14 (-4 to 32)

1(-18 to 19)

-4(-22 to 15)

Movement Episode Count

-16 (-61 to 29)

-15 (-59 to 30)

5 (-40 to 49)

Movement Time

72 (-94 to 238)

60 (-106 to 226)

94 (-260 to 71)

Rest Episode Count

-16 (-61 to 29)

-15 (-59 to 30)

5 (-40 to 49)

Rest Time

-72 (-238 to 94)

-60 (-226 to 106)

-95 (-261 to 71)

Total Distance

983 (-1996 to 3963)

17 (-2963 to 2996)

823 (-2157 to 3803)

Stereotypic Activity Count

-17 (-147 to 113)

13 (-117 to 143)

-14 (-144 to 116)

1029 (-956 to 3014)

1224 (-761 to 3209)

1097 (-888 to 3082)

-3 (-50 to 45)

7 (-41 to 55)

4 (-44 to 52)

Locomotor Clockwise
Revolutions
Locomotor CounterClockwise Revolutions†

Stereotypic Episode Activity
Count
Stereotypic Episode Count
Stereotypy Time

‡

-5 (-29 to 19)
†

-5 (-28 to 19)
§

439 (146 to 732)

-6 (-30 to -18)
§

341 (49 to 633) §

Vertical Activity Count

449 (156 to 747)

Vertical Activity Time†

143 (42 to 244) §

121 (20 to 222) §

109 (8 to 210) §

Vertical Episode Count†

66 (24 to 109) §

55 (13 to 98) §

57 (14 to 100) §

*

Distance is in centimeters, time is in seconds, count and revolution are in numbers.

†

Statistically significant difference between week 4 and week 8 for the sham operated rats.

‡

Statistically significant difference between week 6 and week 8 for the sham operated rats.

§

Bonferroni’s multiple comparison test showed statistical significance between group differences at adjusted P <

0.05.
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Bonferroni’s multiple comparison test showed that at eight weeks post-surgery, compared
to the naïve group, the ACLT+pMMx group had a significantly lower vertical activity
episode count (t = 2.85, adjusted P = 0.029) and vertical activity count (t = 0.015, adjusted
P = 0.019), but similar vertical activity time (t = 2.164, adjusted P = 0.103). Whereas,
Bonferroni’s multiple comparison test showed that at eight weeks post-surgery compared
to the naïve group, the sham group had a similar vertical activity episode count (t = 0.757,
adjusted P = 0.927), vertical activity count (t = 0.757, adjusted P = 0.927), and vertical
activity time (t = 0.267, adjusted P = 1.00).
The OARSI cartilage degeneration scores for MTP and MFC association with percent
ipsilateral weight-bearing and the variables of vertical activity were investigated. At eight
weeks post-surgery, moderate to strong correlations were observed, which were in most
cases statistically significant for MTP and for MFC with percent ipsilateral weight-bearing
(rs = -0.71 , P = 0.022; rs = -0.65, P = 0.040), vertical activity episode count (rs = -0.71, P =
0.020; rs = -0.83 , P = 0.003), vertical activity time (rs = -0.70, P = 0.024; rs = -0.54, P =
0.105), and vertical activity count (rs = -0.59, P = 0.072; rs = -0.68, P = 0.030). The
correlations at four weeks post-surgery were similar. The negative rs values indicated lower
OARSI scores were correlated with higher percentage ipsilateral weight-bearing and higher
vertical activity values.

4.5

Discussion

Our findings demonstrated that percentage ipsilateral weight-bearing and vertical (rearing)
activity, based on statistical significance, differed between the ACLT + pMMx induced
model of post-traumatic knee OA and sham surgery rats. Our data show that these two
behaviours were moderately to strongly associated with the presence of mild to moderate
osteoarthritic structural joint changes.12 Thus, the above findings provide evidence that
these behaviours are consistent with symptoms of post-traumatic knee OA, and may be
adequate for use to distinguish between rats with and without knee OA-like changes when
using the ACLT + pMMx rat model.

128

It is common among research studies to find significant ipsilateral weight-bearing deficits
in a knee OA rat model group when it is compared to a control group.7, 31-33 Most studies of
rat models of post-traumatic knee OA have assessed weight-bearing during the gait cycle
of rats,31-33 and therefore, would not measure static weight-bearing. Most other studies that
did assess static weight-bearing and demonstrated a statistically significant weight bearing
deficit on the ipsilateral hindlimb used MIA-induced OA rat models.7, 22 Studies that have
assessed static weight-bearing for experimental models of post-traumatic knee OA either
found no significant weight-bearing deficit22 or showed a significant difference while using
short follow-up periods34 of usually up to four weeks post-surgery. Such short periods
would only capture the very beginning stages of knee OA-like changes in the ACLT +
pMMx rat model.12
As far as we know, this is the first study to report on exploratory motor behaviour using the
open field tester to assess rats with experimentally induced post-traumatic knee OA-like
changes. The findings indicated that vertical (rearing) activity in the context of spontaneous
locomotor activity may be useful in distinguishing between rats with and without ACLT +
pMMx-induced knee OA-like changes. Findings of previous studies are conflicted on the
utility of vertical activity in distinguishing between a post-traumatic model of knee OA and
control groups in mice. One study found a significant difference in rearing activity between
mice in a naïve group and a surgically destabilized medial meniscus induced model of knee
OA at 16 weeks post-surgery.35 However, that study’s behavioural assessment was very
lengthy, as it lasted 15 hours and used the Laboratory Animal Behavior Observation
Registration and Analysis System (LABORAS) which utilizes vibration and force signals
to detect exploratory motor behaviour.35 On the other hand, a 30 minute assessment in an
open field tester found no significant difference in rearing time up to 12 weeks post-surgery
between a bilateral cruciate ligament injury mouse model and a sham surgery group.19
Thus, the present study may be the first to provide support for vertical activity as a measure
to distinguish between rats of a post-traumatic model of knee OA and control groups.
Vertical activity may be likened to sit-to-stand activity in humans, which is a valuable
performance-based clinical measure of physical function in people with knee OA.36
Compared to age and gender-matched controls, humans with early stage medial knee OA
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have been reported to put less weight on their affected side when transitioning from a
sitting to a standing position.37 Interestingly, these individuals with knee OA reported no
pain at the time of assessment, but had previously been symptomatic.37 Therefore, a
weight-bearing deficit could be related not only to pain but also to limb strength.38
However, another study in humans showed that knee OA-related pain is moderately
correlated with the time taken to perform the sit-to-stand activity.39 Thus, knee OA-related
pain may be associated with a decrease in the number of vertical activity episodes
performed within a given period of time.
Using sham surgery as a control allowed for most of the difference between the groups to
be attributable to the ACLT + pMMx surgery, and consequently to knee OA changes. The
naïve control, further substantiated the strength of our results, by showing a statistically
significant difference with the ACLT + pMMx group, but not with the sham control.
Assessment of exploratory motor behaviour began at four weeks post-surgery, after
allowing post-surgical pain to dissipate and for early stage knee OA-like changes to be
established12. Furthermore, in the present study, the sham group did not develop OA-like
structural changes compared to the development of OA-like changes in older middle-aged
(12 months old) sham-operated rats in a previous study.40
There were some limitations to this study. First, the ACL of the ACLT + pMMx rats were
not reconstructed. Therefore interpreting whether the behavioural changes were
independent of joint instability and attributable only to symptomatic knee OA-like changes
is difficult.7 Second, values for some of the behavioural variables had high within-group
variation. Thus, some statistical analyses may have been too underpowered to detect a
statistically significant difference between the study groups for variables of exploratory
motor behaviour other than the three vertical activity variables. In a future study, this
limitation might be investigated by using larger group sizes and a longer duration for
exploratory motor behaviour assessment. Also, another indication that a future study may
benefit from a larger sample size was evident in the results of the static weight-bearing
assessment where the naïve group’s ipsilateral weight bearing was higher than the ACLT +
pMMx group at week 4 and week 8 post-surgery, but the difference was not statistically
significant at week 4 post-surgery (i.e., adjusted P = 0.103). While, the naïve group had
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almost identical scores to the sham group at both week 4 and week 8 post-surgery, as is
made clear by the adjusted P-value of 1.0. Third, a drug delivery pump was installed,
which makes our findings limited to conditions under which a similar approach is used for
drug delivery. Efforts were taken to reduce the trauma involved in pump installation.
However, it is possible that these surgeries, and the short term analgesics which followed
may influence long term pain pathways. Fourth, changes in exploratory motor behaviour
could reflect pain but also other disturbances. Finally, the assessor of the behavioural
outcomes was not blinded to group allocation, which might have allowed some observer
bias when measuring differences in ipsilateral percent weight-bearing between study
groups.41 Future studies could use a blinded assessor when performing these assessments.

4.6

Conclusions

This study demonstrated that percent ipsilateral weight-bearing and three vertical activity
variables (i.e. vertical activity count, vertical activity time, and vertical activity episode
count) are useful measures to distinguish rats with and without ACLT + pMMx-induced
post-traumatic knee OA-like changes. Our data suggest that these behavioural assays can
be added as valuable functional outcome measures in studies using rat models of OA;
however, their relevance for translational studies of new experimental treatments needs to
be further evaluated.
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4.8

Supplementary data

The following is the supplementary data related to this chapter:

Figure 4.7: No evidence of OA found in the lateral knee joint compartments of ACLT
+ pMMx operated rats
(A) Representative toluidine blue stained sections of knee joints demonstrates healthy
lateral compartment cartilage in anterior cruciate ligament transection and partial medial
meniscectomized (ACLT + pMMx, n = 6) and sham operated animals (n = 5). (B) At 4 and
132

(C) 8 weeks post-surgery, ACLT + pMMx rats showed very minor but statistically
significantly higher OARSI cartilage degeneration scores in the lateral tibial plateau (LTP)
and lateral femoral condyle (LFC) of operated knee joints. (D) Representative toluidine
blue stained sections of the medial knee joint synovium shows minor fibrosis in
ACLT + pMMX rats. (E) Representative toluidine blue stained sections of the lateral knee
joint synovium shows comparable histology between ACLT + pMMX and sham operated
rats. *P < 0.05, **P < 0.005, Mann–Whitney statistical test. The values are presented as
mean with 95% CI for each study group. T = lateral tibia, F = lateral femur.
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Chapter 5

5

General Discussion

In recent years, several studies have been published that investigated the identification,
treatment and lived experiences of symptomatic knee OA to gain a better understanding of
how to prevent or reduce its ill-effects and progression.1-4 These ill-effects include
increasing pain, physical activity limitations, physical dysfunction, psychological
dysfunction, and loss of quality of life.5 At present, there seems to be no single solution;
but the progress that has been made demonstrates the importance of a multifactorial
approach to the identification/diagnosis and treatment of symptomatic knee OA.5, 6
Three domains that can be used to characterize phenotypes of pain in knee OA have
previously been identified.6 These three domains highlight distinct characteristics of
symptomatic knee OA that can be used in identifying, providing prognoses and treating
knee OA.6 These three domains are “knee pathology, psychological distress, and pain
neurophysiology” as stated by Kittelson et al. (2013: p. 422).6 Of particular importance to
the research presented in this thesis was the psychological distress domain, because of its
consistency with the definition used for illness perception and behaviour in this thesis.6

5.1

Measures of illness perception and behaviour

Chapter two of this thesis showed that 16 validated measures of illness perception and
behaviour have been previously used to assess people with knee pain/OA. These measures
fit with Kittelson et al’s examples of measures of psychological distress—measures of fearavoidance beliefs, pain catastrophizing, self-efficacy, and coping.6 This means that the
identified measures fit within the psychological distress domain used to define phenotypes
of pain in knee OA. This supports the importance of the findings in chapter two, showing
chapter two is a useful source of information that summarizes measures in the
psychological distress domain that can be useful in therapy and research of people who
have knee pain/OA. By using a novel strategy of applying four components derived from
the definition used for illness perception and behaviour,11 my research was able to highlight
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the measures’ comprehensiveness in operationalizing the concept in the 16 measures. Thus,
chapter two is a useful resource for clinicians and researchers when they are selecting
measures to assess illness perception and behaviour in people with knee pain/OA.
However, users of these measures are recommended to delve deeper into research on the
measurement properties of each measure before making their final decision to use any of
the 16 measures.12
In chapter two, the primary findings indicated that the QuIKS was the only validated
measure that captures all four components of illness perception and behaviour in the target
sample. This finding supports the QuIKS’s potential to be an important measure in
identifying and providing prognoses for people with early symptoms of knee OA. The
QuIKS could be used alongside measures of knee pain and knee pathology to describe the
phenotype of knee pain in individuals with early symptoms of knee OA. The diverse ways
in which the measures of illness perception and behaviour have been used to account for
changes in pain, physical activity, physical function, psychological function, and quality of
life for people with knee pain/OA speaks to the importance of pursuing future work on the
measurement properties of the QuIKS. When the scoping review was conducted, only one
study had been published about the measurement properties of the QuIKS, and the
publication provided content validation and proof of internal consistency.8 Also, there was
another study which provided construct validation for one of its four subscales.13
Therefore, other measurement properties of the QuIKS needed to be evaluated before it can
be used during the care of people with the early symptoms of knee OA.

5.2
Interval-level measure of illness perception and
behaviour
In chapter three, construct validation was provided for the QuIKS beyond the published
works identified in chapter two. More specifically, a Rasch-refined version of the QuIKS
(QuIKS-R) was developed which has interval-level scaling of illness perception and
behaviour in people with knee pain/OA. The interval-level scaling of illness perception and
behaviour by the QuIKS-R is important because it allows for making interpretation on the
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relative distance between scores. This kind of interpretation is not recommended when
using nominal-level and ordinal-level scaling of measurement which are lower levels of
measurements compared to interval-level measurement. Interestingly, none of the other 15
validated measures of illness perception and behaviour included in the scoping review
obtained validation using Rasch analysis. Based on the findings in chapter two and chapter
three, the QuIKS-R is the first measure to demonstrate interval-level scaling for illness
perception and behaviour among people with knee pain/OA. This is significant, as it puts
the QuIKS-R at the forefront of measures with sound measurement properties that can be
used to discriminate illness perception and behaviour among persons with knee pain/OA.

5.3

Behavioural measures in a rat model of knee OA

A rat model was studied for this thesis at the stages of OA where structural changes in the
knee joint were characteristic of mild-to-moderate knee OA in humans. In chapter four,
ipsilateral weight-bearing deficit and vertical activity limitations were identified as two
behaviours that could potentially enhance the translatability of results from preclinical rat
model research into clinical research settings. The knee pathology and pain
neurophysiology domains of this rat model of post-traumatic knee OA have already been
well characterized in other studies.14-17 The two behaviours that were identified as a part of
this thesis could be considered to fit in the take remedial action component of illness
perception and behaviour, based on the reasoning that these two behaviours might reflect
strategies the rats took to avoid knee symptoms. Furthermore, these two behaviours fall
under the psychological distress domain of phenotypes of pain in knee OA. Thus, they
strengthen this post-traumatic knee OA model for use in preclinical research, because now
all three domains of the phenotypes of pain in knee OA are covered by the rat model.

5.4

Limitations

There are limitations across the three studies in this thesis. Regarding chapter two, the four
components of illness perception and behaviour are not directly part of a theoretical
framework and have not been individually studied and validated. Such validation may
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require expert opinion. However, experts consulted on the scoping review were satisfied
with the formulation of the components and their definitions. Furthermore, the components
and their definitions were informed by prior work on the conceptualization of illness
perception, on the conceptualization of illness behaviour, on people’s lived experience with
knee pain/OA, and were also informed by general theories and models related to how
people respond to being ill.7, 11, 18-20
Regarding chapter three, the results of the psychometric properties of the QuIKS-R are
promising, but have not been verified in an independent sample. It is for this reason that a
team of researchers and I presently engaged in ‘The QuIKS Knee Study’, which is
presented in the future directions section that follows in this chapter. The QuIKS Knee
Study is being conducted to provide further construct validation to, and interpretation of,
scores on the QuIKS-R.
Regarding chapter four, more work needs to be done to provide conclusive findings on the
behavioural measures utility in preclinical trials using the rat model of post-traumatic knee
OA, such as determining whether these behaviours are removed with the use of pain
medication. Such a study would provide more evidence that would verify or refute the
interpretation that these behavioural outcomes were related to pain in knee OA.

5.5

Clinical implications

There are several clinical implications of the findings presented in this thesis. The scoping
review presented in chapter two provides an interpretive review of measures that may be
useful in a multifactorial approach to assessing the phenotype of pain in people with
symptoms of knee OA. The QuIKS-R, presented in chapter three, is a new and promising
tool for assessment within the psychological distress domain of people with early
symptoms of knee OA. Therefore the QuIKS-R could be crucial in identifying issues that
clinicians could address during therapy for people with early symptoms of knee OA.
Ideally it would be used during the initial consultation between the patient and the
clinician. Also, the QuIKS-R could be used to identify people in the community with
emergent chronic OA-like pain who could benefit from conservative treatment such as
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education and exercise. The rat model study presented in chapter four was a ‘bedside-tobench’ work, which used knowledge from human research to inform the investigation of
behaviours related to knee OA in a rat model of post-traumatic knee OA. Therefore,
preclinical work performed using this model might be better translated into clinical
settings, given that the behavioural factors in the model are now better understood.

5.6

Future directions: The QuIKS Knee Study

Currently, we are engaged in an ongoing research project called The QuIKS Knee Study.
The project is investigating the ability of the QuIKS-R to identify people with OA-like
knee pain who are more likely to have decreased physical activity, physical function, and
health-related quality of life. This further validation of the QuIKS-R may prove it to be a
useful measure for identifying, providing prognoses, and informing the therapy of people
with knee OA-like symptoms. The QuIKS-R was created through Rasch analysis of data
from the original 13-item QuIKS, data which were collected using a 35-item prototype
questionnaire. Therefore, it is very important that the QuIKS-R undergo this independent
validation with the new data being collected from its target population using this 13 item
version.
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Appendices
Appendix A Questionnaire to Identify Knee Symptoms (QuIKS)-R

Questionnaire to Identify Knee Symptoms-R (QuIKS-R)
Instructions
Tick one box to answer each question. If you are unclear about how to answer a question,
please give your best answer.

Medications
The following statements describe things you might do to manage your knee pain with
medications.
Tick the box that best describes how often each statement applies to you in the last 2
weeks.
Never

Rarely

Sometimes

Often

Always

1. I take pills before I do some activities to
prevent knee pain.

□

□

□

□

□

2. I take pills after I do some activities to
reduce knee pain.

□

□

□

□

□

3. I carry pills with me just in case my
knees start to hurt.

□

□

□

□

□

0

0

0

1

1

1

1

1

1

2

1

1

2

1

2

Monitoring
The following statements describe how you may monitor your knee symptoms.
Tick the box that best describes your agreement with each of the following statements in
the last 2 weeks.
Strongly

Disagree

Neutral

Agree

Strongly
Agree

Disagree

4. I notice knee pain when kneeling.

□

□

□

□

□

5. My knees feel stiff after sitting or
standing for long periods of time.

□

□

□

□

□

0

0

1

1

1

1

1

1

2

2
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6. My knees hurt after sitting or standing
for long periods of time.

□

□

0

□

1

□

1

□

1

2

Interpreting
The following statements describe how you may interpret your ongoing knee symptoms.
Tick the box that best describes your agreement with each of the following statements in
the last 2 weeks.
Strongly

Disagree

Neutral

Agree

Strongly
Agree

Disagree

7. I talk to family and friends about
things I can do about my knee problems.

□

□

□

□

□

8. I consult my doctor about my knee
problems.

□

□

□

□

□

9. I suspect my knee problems are the
result of getting older.

□

□

□

□

□

10. I suspect my knee problems are
arthritis.

□

□

□

□

□

0

1

0

1

1

0

1

1

0

1

1

1

1

2

2

1

1

2

1

2

Modifying
The following statements describe how you may modify activities in response to knee pain.
Tick the box that best describes your agreement with each of the following statements in
the last 2 weeks.
Strongly

Disagree

Neutral

Agree

Disagree

Strongly
Agree

11. I participate in certain activities less
often to avoid aggravating my knees.

□

□

□

□

□

12. I am considering stopping a
favorite activity due to my knees.

□

□

□

□

□

13. I am considering changing my
exercise routine due to my knee
problems.

□

□

□

□

□

0

0

0

1

1

1

1

1

1

1

1

1

2

2

2
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The conversion table below is for Clinicians Use Only
QuIKS-R raw total score = ____________

QuIKS-R final score = ______________

Conversion Table
Total Raw Score

Final Score

Total Raw Score

Final Score

Total Raw Score

Final Score

0

100

9

66.2

18

29.7

1

94.8

10

59.2

19

26.7

2

90.6

11

52.9

20

23.8

3

87.3

12

48.2

21

20.9

4

84.4

13

44.5

22

17.9

5

81.6

14

41.2

23

14.9

6

78.6

15

38.3

24

11.4

7

75.3

16

35.4

25

6.6

8

71.2

17

32.6

26

0
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